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This work examines the viability of a membrane system to recover salts in urine valuable for 
potential agricultural use, while separating these from any undesired components such as salts 
detrimental to plant growth.  To this end, membranes were compared to processes currently in 
use, or those proposed for future use, for treating sewerage and desalinating brines, as urine is a 
saline solution.  Membrane processes were considered favourable as they generally require less 
energy than the other processes, are modular and mechanically relatively simple, can be used in 
many environments, and usually require no chemical additives to achieve separation. 
Many configurations involving membrane systems would be possible, the most promising 
involving a combination of microfiltration pre-treatment for organics and solids removal, a 
nanofiltration membrane to split the Nitrogen/Potassium/Phosphorous (NPK) from the sodium 
chloride, and a forward osmosis membrane for the final removal of sodium chloride to obtain 
potable water.  The lack of detailed information regarding passing urine through nanofiltration 
membranes meant that the remainder of the project focussed on experimentally determining 
whether a nanofiltration membrane could perform the required salt separation.  Three DOW-
Filmtec polyamide membranes were chosen, namely the NF 270, NF 90 and XLE membranes, 
as they are readily available, commercially used membranes and polyamide seemed to be the 
most promising membrane material based on a review of the available literature.  
Two solutions were tested using the membranes, namely stored urine and a synthetic urine 
solution.  The flux achieved by the membranes, 80 – 100 l/m
2
.h for NF 270, 6 – 8 l/m
2
.h for 
NF 90, and 4 – 10 l/m
2
.h for XLE, followed the order of the Molecular Weight Cut-off 
(MWCO), would be sufficient for the Reinvent the Toilet Challenge (RTTC) purposes and was 
similar to literature values.  The flux was still increasing with increasing Transmembrane 
Pressure (TMP) between 800 and 1250 kPa for the XLE membrane, indicating that higher TMP 
conditions are usable without loss of energy efficiency.   Fouling resulted in negligible decrease 
in flux for the NF 270 membrane, a 15 % decrease in flux for the NF 90 and an 18 % decrease 
for the XLE membrane, all of which are within tolerable limits.  The NF270 had the highest 
rejection for phosphorous (80%) and lowest for Na
+
 (40%), which suggests that this membrane 
may be the most useful if phosphorous recovery was of primary importance.   
The transport model suggests a high separation between phosphorous and sodium and 
ammonium and sodium, this was supported for phosphorous by previous work in literature but 
not during these trials.  Neither literature nor these trials support the transport model with the 
ammonium/sodium split.  The results suggest that perhaps using nanofiltration membranes for 
the recovery of phosphorous in conjunction with a second type of technology for the recovery of 
nitrogen, such as ammonia stripping, will be a viable process rather than membranes alone.  
iii 
 
TABLE OF CONTENTS 
DECLARATION ..........................................................................................I 
ABSTRACT ................................................................................................ II 
TABLE OF CONTENTS ......................................................................... III 
LIST OF FIGURES ................................................................................... V 
LIST OF TABLES .................................................................................... VI 
LIST OF EQUATIONS .......................................................................... VII 
SYMBOLS AND ABBREVIATIONS ................................................. VIII 
1 INTRODUCTION ............................................................................ 1 
1.1 CONTEXT OF THE STUDY .................................................................................................. 1 
1.2 PURPOSE OF THE STUDY ................................................................................................... 2 
1.3 RESEARCH OUTCOMES ..................................................................................................... 2 
1.4 SIGNIFICANCE OF THE STUDY ........................................................................................... 3 
1.5 LIMITATIONS OF THE STUDY ............................................................................................ 3 
2 LITERATURE REVIEW ................................................................ 4 
2.1 INTRODUCTION ................................................................................................................. 4 
2.2 URINE BACKGROUND ....................................................................................................... 4 
2.3 TREATMENT OBJECTIVES ................................................................................................. 6 
2.3.1 DISINFECTION ................................................................................................................... 6 
2.3.2 VOLUME REDUCTION ........................................................................................................ 6 
2.3.3 STABILISATION ................................................................................................................. 7 
2.3.4 PHOSPHOROUS RECOVERY ................................................................................................ 8 
2.3.5 NITROGEN RECOVERY ...................................................................................................... 8 
2.3.6 NUTRIENT REMOVAL ........................................................................................................ 8 
2.3.7 MICRO-POLLUTANT REMOVAL ......................................................................................... 9 
2.4 TREATMENT PROCESSES FOR URINE DISPOSAL OR BENEFICIATION ............................... 9 
2.4.1 EVAPORATION .................................................................................................................. 9 
2.4.2 MEMBRANE FILTRATION ................................................................................................ 13 
2.4.3 NITROGEN AND AMMONIA RECOVERY ........................................................................... 17 
2.4.4 OTHER ............................................................................................................................ 19 
2.5 PROCESS SELECTION ...................................................................................................... 21 
2.5.1 TREATMENT PROCESS ANALYSIS .................................................................................... 21 
2.5.2 DESIGN CONSTRAINTS .................................................................................................... 24 
2.5.3 URINE TREATMENT PROCESS SELECTION ....................................................................... 25 
2.6 NANOFILTRATION .......................................................................................................... 27 
2.6.1 DEFINITION ..................................................................................................................... 27 
2.6.2 SEPARATION MECHANISM .............................................................................................. 28 
2.6.3 MEMBRANE TYPES ......................................................................................................... 29 
2.6.4 FOULING ......................................................................................................................... 30 
2.6.5 NANOFILTRATION OF URINE ............................................................................................ 31 




3 MATERIALS AND METHODS ................................................... 37 
3.1 RESEARCH DESIGN ......................................................................................................... 37 
3.2 EXPERIMENTAL DESIGN ................................................................................................. 39 
3.2.1 NANOFILTRATION EQUIPMENT ....................................................................................... 39 
3.2.2 EXPERIMENTAL PROCEDURE .......................................................................................... 41 
3.2.3 ANALYTICAL EQUIPMENT ............................................................................................... 41 
3.3 DATA ANALYSIS ............................................................................................................ 44 
3.3.1 TRANSPORT MODEL ........................................................................................................ 44 
3.3.2 EFFECT OF MEMBRANE AREA ......................................................................................... 45 
3.3.3 WATER RECOVERY ......................................................................................................... 45 
3.3.4 SEPARATION FACTORS .................................................................................................... 46 
4 RESULTS AND DISCUSSION ..................................................... 47 
4.1 ANALYTICAL EQUIPMENT .............................................................................................. 47 
4.1.1 SPECTROQUANT NOVA 60 OPERATION ........................................................................... 47 
4.1.2 ANALYTICAL PRECISION ................................................................................................. 48 
4.2 FLUX RESULTS ............................................................................................................... 50 
4.2.1 WATER FLUX VERSUS TRANSMEMBRANE PRESSURE ...................................................... 50 
4.2.2 SYNTHETIC AND STORED URINE FLUXES ........................................................................ 51 
4.2.3 SOLUTION FLUX VERSUS TRANSMEMBRANE PRESSURE .................................................. 52 
4.2.4 FOULING POTENTIAL ...................................................................................................... 53 
4.3 REJECTION RESULTS ...................................................................................................... 54 
4.3.1 REJECTIONS BY MEMBRANE TYPE .................................................................................. 54 
4.3.2 REJECTION VS TRANSMEMBRANE PRESSURE .................................................................. 56 
4.3.3 COMPARISON TO LITERATURE ........................................................................................ 57 
4.4 NANOFILTRATION USAGE .............................................................................................. 57 
4.5 TRANSPORT MODEL ....................................................................................................... 58 
4.5.1 EFFECT OF INCREASING MEMBRANE AREA ON FEED CONCENTRATION ............................ 58 
4.5.2 EFFECT OF INCREASING MEMBRANE AREA ON PERMEATE CONCENTRATION ................... 58 
4.5.3 WATER RECOVERY ......................................................................................................... 59 
4.5.4 SEPARATION FACTORS .................................................................................................... 60 
5 CONCLUSION ............................................................................... 62 
6 RECOMMENDATIONS................................................................ 64 
7 REFERENCES ................................................................................ 65 
8 APPENDICES ................................................................................. 69 
8.1 URINE COMPOSITION ..................................................................................................... 69 
8.1.1 FRESH URINE .................................................................................................................. 69 
8.2 ANALYSIS EQUIPMENT ................................................................................................... 71 
8.2.1 SPECTROQUANT NOVA 60 SOPS ..................................................................................... 71 
8.3 RESULT SHEETS.............................................................................................................. 80 
8.3.1 WATER FLUX .................................................................................................................. 80 
8.3.2 SYNTHETIC URINE .......................................................................................................... 83 




LIST OF FIGURES 
Figure 1: Urea Hydrolysis ............................................................................................................. 7 
Figure 2: Vapour Compression Distillation [13]......................................................................... 10 
Figure 3: Relative Comparison of Desalination Costs and energy requirements [20] ................ 12 
Figure 4: Passarell Process [19] .................................................................................................. 13 
Figure 5: Electrodialysis Stack [29] ............................................................................................ 15 
Figure 6: Process Flow Diagram 1 .............................................................................................. 26 
Figure 7: Process Flow Diagram 2 .............................................................................................. 26 
Figure 8: Process Flow Diagram 3 .............................................................................................. 27 
Figure 9: Fresh and synthetic urine rejections from Pronk et al. [22] ......................................... 32 
Figure 10: Salt solution rejections from Wang et al. [50–52] ..................................................... 33 
Figure 11: Summary of Experimental Results [22, 50–53] ........................................................ 34 
Figure 12: High Pressure Cross-flow Membrane Laboratory Rig .............................................. 40 
Figure 13: Initial Concentration of Synthetic Urine.................................................................... 48 
Figure 14: Initial Concentration of Stored Urine ........................................................................ 49 
Figure 15: Water flux vs transmembrane pressure for the 3 membranes .................................... 50 
Figure 16: Average Synthetic and Stored urine flux for 3 membranes, at a TMP of 800 kPa .... 51 
Figure 17: Flux vs Time at constant TMP .................................................................................. 52 
Figure 18: Synthetic and stored urine Flux vs TMP for XLE membranes.................................. 53 
Figure 19: Water flux through the 3 membranes, before and after filtration .............................. 54 
Figure 20: Rejections for Synthetic and Stored Urine for 3 membranes, at a TMP of 800 kPa . 55 
Figure 21: Rejection for synthetic and stored urine vs TMP for XLE membrane ...................... 56 
Figure 22: Literature Rejections and Experimental Rejections for NF 270 membrane .............. 57 
Figure 23: Concentration of species on the feed side .................................................................. 58 
Figure 24: Concentration profile of species on permeate side .................................................... 59 
Figure 25: Concentration profile vs water recovery for NF90 with synthetic urine ................... 60 





LIST OF TABLES 
Table 1: Compounds forming approximately 80% of fresh urine solutes [7, 8] ........................... 5 
Table 2: Processing Methods ...................................................................................................... 22 
Table 3: Membrane Processes ..................................................................................................... 23 
Table 4: Udert et al. synthetic urine recipe [11] .......................................................................... 37 
Table 5: Stored and Synthetic Urine Composition and Analytical Precision ............................. 49 
Table 6: Constituents of Human Urine [8] .................................................................................. 69 
Table 7: NF 90 Distilled Water Permeability ............................................................................. 80 
Table 8: NF 270 Distilled Water Permeability............................................................................ 81 
Table 9: XLE Distilled Water Permeability ................................................................................ 82 
Table 10: Experimental data of synthetic urine run through NF 270 membrane ........................ 83 
Table 11: Synthetic urine composition ....................................................................................... 83 
Table 12: Water flux through fouled NF 270 membrane ............................................................ 83 
Table 13: Chemical analysis for synthetic urine through NF 270 membrane ............................. 84 
Table 14: Experimental data of synthetic urine run through NF 90 membrane .......................... 85 
Table 15: Water flux through fouled NF 90 membrane .............................................................. 85 
Table 16: Chemical analysis for synthetic urine through NF 90 membrane ............................... 86 
Table 17: Experimental data of synthetic urine run through XLE membrane ............................ 87 
Table 18: Water flux through fouled XLE membrane ................................................................ 87 
Table 19: Chemical analysis for synthetic urine through XLE membrane ................................. 88 
Table 20: Experimental data of stored urine run through NF 270 membrane ............................ 89 
Table 21: Water flux through fouled NF 270 membrane ............................................................ 89 
Table 22: Chemical analysis for stored urine through NF 270 membrane ................................. 90 
Table 23: Experimental data of stored urine run through NF 90 membrane .............................. 91 
Table 24: Water flux through fouled NF 90 membrane .............................................................. 91 
Table 25: Chemical analysis for stored urine through NF 90 membrane ................................... 92 
Table 26: Experimental data of stored urine run through XLE membrane ................................. 93 
Table 27: Water flux through fouled XLE membrane ................................................................ 93 




LIST OF EQUATIONS 
Equation 1: Urea Hydrolysis [10] ................................................................................................. 7 
Equation 2: Ammonium equilibrium [10] ..................................................................................... 7 
Equation 3: Transmittance .......................................................................................................... 42 
Equation 4: Absorbance .............................................................................................................. 42 
Equation 5: Absorbance, Concentration relationship .................................................................. 42 
Equation 6: Solute Flux from Water Flux ................................................................................... 44 
Equation 7: Solute Flux ............................................................................................................... 44 
Equation 8: Solute Rejection ....................................................................................................... 44 
Equation 9: Solute Concentration in Permeate ........................................................................... 44 
Equation 10 ................................................................................................................................. 44 
Equation 11: Solute Mass Flowrate ............................................................................................ 45 
Equation 12: Water Flux at constant TMP .................................................................................. 45 
Equation 13: Transmembrane Pressure ....................................................................................... 45 
Equation 14: Water Recovery ..................................................................................................... 46 




SYMBOLS AND ABBREVIATIONS 
AES  Air Evaporation System 
COD  Chemical Oxygen Demand  
DSPM  Donnan-Steric Pore Model 
ES Model Electrostatic and Steric-hindrance Model 
FO  Forward Osmosis 
HAP  Hydroxyapatite 
IBDU  Isobutylaldehyde-diurea 
MBBR  Moving Bed Biological Reactor 
MP-AES Microwave Plasma – Atomic Emission Spectrometer 
MF  Microfiltration 
MWCO Molecular Weight Cut-off 
NF  Nanofiltration 
NP  Nernst-Planck 
NPK  Nitrogen, phosphorous and potassium 
PRG  Pollution Research Group 
RO  Reverse Osmosis 
RTTC  Re-invent the Toilet Challenge 
SHP Model Steric-hindrance Pore Model 
TIMES  Thermoelectric Integrated Membrane Evaporation System 
TMP  Transmembrane Pressure 
TMS Model Teorell-Meyer-Sievers Model 
UDT  Urine Diverting Toilet 
UF  Ultrafiltration 




1.1 Context of the study 
The Bill & Melinda Gates Foundation has provided funding, to the University of KwaZulu-
Natal, Pollution Research Group (PRG), amongst others, for a program known as the Reinvent 
the Toilet Challenge (RTTC).  The engineering challenge to be addressed by the project is to re-
think the entire toilet concept, eventually aiming to produce a system that can replace existing 
flush toilet technology with an equal, or better, user experience while treating the waste as a 
valuable resource.  The outcome of this project would help to alleviate sanitation problems for 
approximately a third of the world’s population, living in poverty in developing countries, who 
do not currently have access to modern sanitation systems.  Further details regarding this project 
and others pursuing the same goal can be viewed on the Bill & Melinda Gates Foundation 
website [1]. 
Conventional water-flush toilets connected to waterborne sewerage systems and centralised 
treatment facilities rarely recover any potentially useful components from the waste being 
processed.  It has been shown by agricultural experiments that waste can be a safe and valuable 
fertiliser [2, 3]. Due to the relatively low concentration of nutrients in the waste, compared to 
commercial fertiliser, the products would need to be used within a limited radius to be 
financially viable and environmentally profitable. 
Thus the primary objective of the challenge is to produce a self-sustaining toilet that is able to 
convert human waste into sterilized fertilizer, potable water, mineral salts and energy suitable 
for powering the process. The waste processing facility will be off-grid, with no connection to 




1.2 Purpose of the study 
Most of the nutrients present in human excreta are concentrated in the urine [2, 4], while most 
of the pathogens, apart from micro-pollutants, are concentrated in the faeces.  Treating urine and 
recovering these nutrients is a key process of ensuring the economic viability of the new toilet 
system.     
This study focuses solely on the processing of urine, most likely entering the proposed excreta 
treatment system via urine diverting toilets.  Membrane filtration has been identified as being 
potentially useful to process urine in the RTTC context, as membrane systems are generally 
lower in energy consumption and in mechanical complexity than corresponding thermally or 
biologically based systems currently used in waste water treatment and desalination processes.  
The purpose of this study was to place membranes in the context of other possible treatment 
options and to identify the key knowledge gaps and fill in the knowledge through 
experimentation, focussing specifically on nanofiltration. 
Some research has been done in this area but lacks details necessary for design purposes, such 
as fouling, flux, water recovery as well as the operating pressures used.  The research was also 
only conducted on fresh urine or a synthetic version thereof.  This study will help to quantify 
these to some degree. 
1.3 Research Outcomes 
Analysis and experimental exploration of a nanofiltration membrane system, in the 
context of potential urine treatment processes 
i. Place membrane processes in the context of urine treatment by conducting a literature 
review of the current and developing methods used for urine processing, as well as for 
general solid-liquid and salt extractions from saline solutions, both on small and large scale. 
ii. Identify the knowledge gaps which currently prevent the use of membrane systems for 
processing urine successfully beyond bench scale. 
iii. Explore the knowledge gaps for the use of nanofiltration membranes through suitable 
experimentation.  Specifically, to determine if nanofiltration membranes are capable of 
achieving an adequate separation between nutrients useful for fertilizer and sodium 





1.4 Significance of the study 
While membranes have been used extensively to treat and desalinate water their application in 
the treatment of sewage water, and urine in particular, has not been widely explored.  This study 
aims to determine if using membranes to treat urine is currently feasible, given available 
membrane technology.  The study provides data regarding the separation potential of 
nanofiltration membranes in the key area of separating valuable components from unwanted 
components in the urine feed.  The flux achievable and the fouling observed will also be 
discussed.  In addition, the work will be done on both synthetic urine, as a basis for comparison, 
and stored urine, which has not been done before.  This study will help to determine if a 
membrane system is worth pursuing or if another approach should be considered. 
1.5 Limitations of the study 
The processes considered here for treating urine are limited to those which have already been 
used for the treatment of waste water or the desalination of salt water, as these are seen as 
processes currently having the greatest potential for urine treatment.   
The prospective treatment system also has limits set by the Bill & Melinda Gates Foundation as 
follows: the system should be robust and modular; consumables, including chemical additives, 
should be kept to a minimum; little to no energy should come from outside the treatment plant, 
although the exact energy source is not considered here; and the system should be universally 
applicable in terms of geography. 
The membrane processes considered for experimentation are further restrained by those 
currently widely available and technically possible within the PRG laboratory.  These are 
reverse osmosis, nanofiltration, forward osmosis, ultrafiltration and microfiltration. 
The variation of feed properties and experimental parameters, such as temperature and pressure, 
for the experiments are limited both by time, in terms of amount of variability and number of 
chemical analyses possible, and analytical equipment availability, in terms of number of 
chemical analyses kits.  The parameters and number of measurements conducted are also 
limited by the operating characteristics of the equipment used, specifically the low permeate 




2 LITERATURE REVIEW 
2.1 Introduction 
This literature review is broken down into five major research areas that together fulfil the first 
two objectives stated in section 1.3 and form the basis of the experimental section of the study.  
The first area covered is a background on urine, focusing on the composition of urine and why it 
can be a valuable resource.  This section will serve as a further explanation of why this study is 
taking place and what value it may have.   
Next the various objectives considered, when selecting a suitable process to treat urine, are 
explained.  Identifying objectives of treating urine allows for an easy grouping of the treatment 
processes and aids in comparing processes and deciding on the most advantageous processes for 
the purposes of this study.  Included here are also comments on the types of processes 
associated with the treatment objective as well as the degree that this is covered in literature and 
industry. 
This then leads to an explanation of the current and proposed processes of treating urine.  A 
brief explanation of each process is given, along with a summary of the processes, compiled 
from an analysis of the literature in a table format for ease of comparison. 
This summary is then used, along with experimental constraints stipulated in section 1.5 and 
explained in section 2.5.1, to define the membrane processes considered for the final treatment 
system.  The processes to be considered are found by eliminating the unsuitable processes and 
selecting the most favourable combination of the remaining processes to achieve the necessary 
separation of valuables from the urine. 
The last section provides further details on nanofiltration to provide a basis for the design of the 
experiments that follow. 
2.2 Urine Background 
Urine is a by-product of the body, formed in the kidneys, and is a means of excreting excess 
salts, by-products of cellular metabolism and any other soluble wastes that may be present in the 
body.  Many of these soluble substances are rich in nitrogen resulting in urine containing, on 
average, 80 % of the nitrogen and 50 % of the phosphorus excreted from the human body [2, 4].   
All nutrients not used for energy or cell generation in the human body are expelled as waste; 
nitrogen, phosphorous and potassium (NPK) are present in urine in forms that can readily be 
taken up by plants [5].   Recovery of these components provides the opportunity to (i) produce 
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an agricultural product with an economic value, for example total phosphorous produced from 
urine was approximately 1.68 million tons in 2009 [6], and (ii) close the nutrient cycle.   
The waste components that must be separated from urine before it can be used as a fertiliser 
product include: sodium chloride, as too much sodium chloride has a negative impact on plant 
growth; and pharmaceutical compounds and endocrine disruptors, which build up in the 
environment and can be hazardous if consumed by humans.  Urine diverting toilets (UDTs), 
which are toilets that collect urine separately from faeces, are seen as potential collection points 
for a toilet system [1].  Due to the human element in the use of UDTs, some cross 
contamination of the urine is to be expected.  This means that some faecal matter may also be 
present in the urine stream and this will also have to be removed before use as fertiliser.  
Table 1 shows the variation in urine composition.  This variance is due to many factors 
including diet, which has a significant effect on pH and nutrient composition, and health, along 
with the accompanying medication taken, of the source [7, 8]. 







36 700 46 700 
Nutrient - Potassium Potassium 39.1 750 2 610 4.6% 
Nutrient - Phosphorous Phosphorous 31 410 1 070 1.9% 
Nutrient - Nitrogen 
Urea 60.1 9 300 23 300 40.7% 
Ammonia 17 200 730 1.3% 
Nutrient - Other 
Bicarbonate 61 20 560 1.0% 
Calcium 40.1 30 390 0.7% 
Other 
   
0.3% 
Pharma/Organics 
Creatinine 113.1 670 2150 3.8% 
Hippuric Acid 179.2 50 1670 2.9% 
Citric Acid 192.1 90 930 1.6% 
Other 
   
13.7% 
Undesirable 
Sodium 23 1170 4390 7.7% 
Chloride 35.5 1870 8400 14.7% 
Sulphur 32.1 163 1800 3.1% 
Other 
   
1.5% 
Table 1: Compounds forming approximately 80% of fresh urine solutes [7, 8] 




2.3 Treatment Objectives 
Research on urine processing indicates that the treatment processes, described in section 2.4, 
can be broken down into seven objectives [5].  The methods considered would aim to fulfil one 
or more of these objectives.  Each of these objectives is explained below: 
2.3.1 Disinfection 
Urine can contain pathogenic organisms and prions, pathogenic agents resulting from protein in 
a misfolded form, which are undesirable when urine or any by-products may come into contact 
with humans, directly or indirectly, as these pathogens could spread disease [5].  Contamination 
with faecal matter is also possible, depending on the separation system used at the urine source, 
and this is undesirable not only because of the risk of disease but also because the faecal 
particles may interfere and hinder processes used downstream, such as causing fouling in 
membrane processes.  
 Although work has been done in the wastewater field to disinfect water, not much research has 
been done with regards to purely urine disinfection.  Many processes will have some 
disinfecting potential but the effect of storage time on indicator pathogen deactivation has been 
studied most extensively [5].  The disinfection is achieved due to the rise in pH during urea 
hydrolysis resulting in the production of ammonia, which is a biocide thereby deactivating 
pathogens.   
2.3.2 Volume Reduction 
As discussed in section 2.2 urine contains nitrogen and phosphorous and has potential use as a 
fertiliser.  The nitrogen and phosphorous concentrations in urine are far lower than commercial 
fertilizer.  Therefore, storage, transport and application costs for commercial fertiliser would be 
far lower for commercial fertiliser than for urine.  Unless this cost difference can be offset by 
the purchasing cost of the fertiliser, it will not be feasible to use urine without concentrating the 
nutrients.  As an illustration of this problem: an average urine sample may contain around 0.4 –
 1 g/l Phosphorous and around 7 – 9 g/l Nitrogen [2], while an average fertiliser may contain 38 
g/l Phosphorous and 35 g/l Nitrogen [9].  A by-product of any volume reduction would be 
water, which, if processed properly within the treatment system, could be re-introduced into the 
local water system or used directly to fulfil any water requirements. 
Volume reduction has been studied thoroughly for waste water and brines, with some studies 
done on urine [5].  The most promising technologies for this area include: evaporation, which 
can further be broken down into various possible technologies; or some type of high rejection 




The single largest component of fresh urine, other than water, is urea, with a concentration 
between 9.3 and 23.3 g/l [7].  Urea contains much of the nitrogen in urine, it can be used 
directly as a fertiliser, if clean enough, and is relatively easily granulated.  Therefore, for many 
applications it is desirable for the urea to remain in this form.  However microbial activity 
causes organic matter to degrade, generating odours, and causing urea to hydrolyse [5].  The 




→     2𝑁𝐻4
+ +𝐻𝐶𝑂3
− + 𝑂𝐻− 
Equation 1: Urea Hydrolysis [10] 




+ + 𝑂𝐻−↔𝑁𝐻3(𝑎𝑞) + 𝐻2𝑂               𝑝𝐾𝑎 = 9.3 @ 25°𝐶 
Equation 2: Ammonium equilibrium [10] 
Urea hydrolysis, depicted in Figure 1, causes the pH of the urine to increase to around 9.2 [11]; 
the precipitation of low solubility compounds such as struvite and hydroxyapatite (HAP) then 
occurs [11]; and nitrogen volatility, in the form of ammonia NH3, increases [5].  The formation 
of volatile ammonia could lead to significant nitrogen losses, which would decrease the amount 















Figure 1: Urea Hydrolysis 
Various processes to stabilise urea have been studied with the most promising processes 




2.3.4 Phosphorous Recovery 
Phosphorous is mainly used in the fertiliser industry and is obtained through mining 
phosphorite, phosphate rich ore.  This means that phosphate is a limited resource, although 
depletion of the ore is not as much a cause for concern as the decrease in the ore quality, in 
terms of phosphate concentration, which will lead to a possible price increase [6].  This means 
that recovering phosphorous from urine could be reasonably profitable in the near future, if 
suitable infrastructure for mass collection of urine is developed [6]. 
The recovery of phosphorous from urine is currently being studied quite extensively, with the 
main process under investigation being struvite and HAP precipitation [5]. 
2.3.5 Nitrogen Recovery 
Nitrogen is an abundant resource, as it makes up 78% of the atmosphere.  The problem is that 
the Haber-Bosch process, the process currently used in capturing nitrogen, and reacting it with 
hydrogen to convert it to ammonia, is energy intensive.  Urine contains nitrogen in an already 
bonded form, urea.  Recovering this could be useful in offsetting any other operating costs [5]. 
Nitrogen recovery from urine has not been studied as extensively as phosphorous recovery but 
some promising processes exist.  Processes include ion-exchange, ammonia stripping and 
isobutylaldehyde-diurea (IBDU) precipitation [5]. 
2.3.6 Nutrient Removal 
Even when urine is depleted of organics and pathogens, releasing the urine into the aquatic 
environment, be it river, dam or sea, can still cause problems for the local ecosystem.  Urine  
has high nutrient concentrations, in the forms of nitrogen and phosphorous, which can cause 
problems such as excess algae growth, shifts in local species populations, dissolved oxygen 
deficit, production of toxins and excess nitrates in drinking water [5].  To control water 
pollution, it is possible to remove these nutrient without recovery.  An example of this would be 
the conversion of any nitrogen present in the urine to N2, which can be safely released into the 
atmosphere. 
The processes used to achieve this include: biological oxidation of ammonia, with nitrite as the 
electron acceptor (the anammox process), and electrochemical oxidation of ammonia as well as 





2.3.7 Micro-pollutant Removal 
Any of the pharmaceuticals and chemicals humans consume are excreted via urine along with 
many excess compounds the body produces.  These are known as micro-pollutants and if they 
are released, along with fertiliser or into the water system, they can accumulate in the 
environment and may cause health problems for humans, who would consume them indirectly 
via plant and animal uptake [5].  Unless the micro-pollutants have a short life-cycle, or the 
ground or water will not be used by humans directly or indirectly, the micro-pollutants in urine 
should be removed or eliminated before use as fertiliser, or release into the water system.   
Elimination of micro-pollutants uses processes similar to that of nutrient removal, mainly 
oxidation and adsorption, which are adversely affected by high Chemical Oxygen Demand 
(COD).  Removal of micro-pollutants uses membranes and precipitation with processes such as 
electrodialysis, nanofiltration, ozonation and advanced oxidation [5]. 
2.4 Treatment Processes for Urine Disposal or Beneficiation 
The treatment processes can be split into four general categories and are explained below: 
2.4.1 Evaporation 
 Vapour Compression Distillation 2.4.1.1
In a vapour compression distillation (VCD) process, shown in Figure 2 below, saturated steam, 
coming from the evaporation of water from urine in the boiling chamber, is compressed to 
increase its temperature.  This superheated steam is sent through the boiling chamber in a 
heating element.  Here it releases latent heat through condensation into the surrounding urine, 
which results in further water evaporation and formation of saturated steam [12].  The now 
condensed steam then flows through the feed tank to preheat the feed solution.  This method 
recovers 96 % of the water with an energy requirement of between 277 and 396 MJ/m
3
 of water 
recovered [5].  The brine could potentially be used as a fertilizer but the presence of sodium 




Figure 2: Vapour Compression Distillation [13] 
The problems with this process include high energy requirements and the loss of ammonia 
during evaporation.  Ammonia evaporation can be controlled through urine acidification or 
using fresh non-hydrolysed urine [5].   
 Thermoelectric Integrated Membrane Evaporation System 2.4.1.2
The TIMES process involves the pre-treatment of the urine, with either ozone or ultra-violet 
light and sulphuric acid.  The urine is then heated and sent through hollow fibre membranes in a 
low pressure chamber, which promotes evaporation through the membrane.  The now clean 
water vapour is condensed [5, 14].  As with VCD the brine could potentially be used as a 
fertilizer but the presence of sodium chloride and pharmaceuticals would necessitate further 
treatment. 
With proper heat integration the energy requirements for the process can be well controlled.  
The main challenges come with the selection of the proper membrane, achieving the desired 
separation and controlling fouling [5]. 
 Air Evaporation System 2.4.1.3
When treating urine or any salt solution, one of the problems is the resulting brine, which then 
has to be disposed or sent for further treatment.  In an air evaporation system (AES), the urine is 
pre-treated to prevent hydrolysis and sent to a wick evaporator.  Hot air is then used to 
evaporate the water in the urine and leave behind a solid, thereby negating the problem of brine 




This process results in a near 100% removal of the water in the urine and an easily manageable 
solid.  The challenges with the process include: urine pre-treatment to ensure only water and no 
other volatiles, such as ammonia, evaporate; removal of sodium chloride from the other salts; 
and the large amounts of energy required for heating the air, with difficult heat and water 
recovery options. 
 Lyophilisation/Freeze-thaw 2.4.1.4
One method to concentrate the nutrients in urine, which is beneficial to transport costs, is 
lyophilisation.  The urine is frozen and the water is allowed to sublimate at a slightly elevated 
temperature.  
Although the process can concentrate about 80% of the nutrients in 25% of the original volume, 
the energy requirements are prohibitively large, especially in hot climates, and there is a 
possibility of some nitrogen loss through ammonia evaporation, if the urine is not pre-treated 
[5]. 
 Multi-stage Flash Evaporation 2.4.1.5
Multi-stage flash is a process where the liquid, in this case urine, is evaporated in chambers with 
successively lower pressure.  To achieve this, urine is heated to the boiling point in the first 
stage.  The urine and resulting steam at the boiling point enter the second chamber which is at a 
lower pressure.  The steam from the first effect is condensed in the second stage, releasing latent 
heat which is used for further evaporation.  Therefore the liquid requires a lower temperature to 
effect evaporation. This procedure continues for the required number of stages and the 
remaining brine is pumped out after the last stage [5]. 
Based on the usage of this process in water desalination it is expected that only around 15% of 
the urine entering the system would be converted to water, although this has yet to be 
investigated [15].  The process is reasonably energy efficient, using about 90 MJ.m
-3
of water 
produced [5].  The main energy loss comes from the exit condensate.  Besides the energy 
required, some of the volatiles in the urine, such as ammonia, may be lost if the urine is not pre-
treated properly. 
 Solar Evaporation 2.4.1.6
Solar humidification-dehumidification is a process currently used to desalinate seawater by 
successive heating, evaporating, and condensing of the humid air.  The process takes place in a 
solar still, with basic units having the solar heat section and condensation section together, and 
more advanced units separating the two.  If designed properly, significant heat can be recovered 
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from the condensation step and returned to the heating chamber.  This process mimics the 
natural water cycle over a much shorter period [16–18]. 
There have been some studies using solar energy to recover nutrients form urine [16, 18] but the 
problems in all the systems include difficulty in efficiently capturing and storing the solar 
energy.  This inefficiency means that the system would have a relatively high capital cost to be 
large enough to achieve sufficient flow to process urine from a significant number of homes.  
The other problem is that any solar process would be inherently tied to areas with a suitable 
climate and plenty of direct sunlight, ruling out many countries and geographies. 
 Passarell Process 2.4.1.7
The Passarell process is a new technology used to desalinate seawater [20].  The process 
combines accelerated distillation and advanced vapour compression to produce potable water.  
The process allows for high-energy integration and recovery, and pilot plants show that this 
method is currently the most cost effective, industrially viable desalination process, as seen in 
the charts from Figure 3.  Figure 4 shows the scheme of the process.  The sea water is pre-
heated and sent to the evaporator where the evaporation is achieved by low pressure rather than 
high heat.  This low pressure is induced by the compression and subsequent condensation of the 
water vapour.  The heat from the condensed liquid is recovered by heat interchange with the sea 
water feed [19, 20]. 
This technology has not been tested with urine but problems that may arise include ammonia 
loss through evaporation, unless the urine is pre-treated, and the need of large amounts of 
electricity to power the compressor.  
 





Figure 4: Passarell Process [19] 
2.4.2 Membrane Filtration 
 Micro and Ultrafiltration 2.4.2.1
Micro and ultrafiltration, used in waste water treatment, use membranes with pore sizes ranging 
from 0.1 to 10 μm and 0.001 to 0.1 μm respectively [21].  Microfiltration is able to remove large 
particles, suspended solids, all bacteria and many viruses but for complete virus removal 
ultrafiltration is required [21]. 
These membranes have been used as pre-treatment steps in some experiments dealing with urine 
but they were not the focus of the experiments and no details of their effectiveness have been 
found [5, 22].  It is expected that they will perform similarly well with urine treatment, in 
removing bacterial and viral contaminants, as they have with wastewater treatment.  The only 





Nanofiltration (NF) membranes are frequently used in wastewater filtration to remove 
contaminants, as well as in desalination for salt removal.  The membranes have pore sizes 
around 1nm, which enable the rejection of dissolved molecules while allowing small ions and 
un-charged molecules to pass through.  The pressures used in nanofiltration are far lower than 
reverse osmosis, and therefore the electricity costs are lower.  Nanofiltration can be used for 
polyvalent, divalent and, depending on the membrane, monovalent ion removal [22].  
The problem with using nanofiltration to achieve this separation is that with completely or 
partially hydrolysed urine a significant amount of ammonia passes through the membrane, thus 
losing nitrogen unless further recovery is attempted [22]. 
 Forward Osmosis 2.4.2.3
Forward osmosis is the process whereby the solvent diffuses through a semi-permeable 
membrane from a volume of low solute concentration, the feed, to a volume of high solute 
concentration, the draw solution, until the solute concentrations on either side are equal.  This 
process requires no added energy and is driven solely by the concentration difference, i.e. the 
osmotic pressure difference.  Forward osmosis has been studied extensively for use in sea water 
desalination [23] and to some extent in urine treatment [24, 25].  The process produces a 
concentrated solution, which must be treated to produce potable water. 
A draw solution which can be separated from water with minimal energy input, such as an 
ammonium carbonate solution, is important as this will be the major energy requirement.  
An ammonium carbonate draw solution, used in previous urine and sea water experiments [26], 
requires a low heat input to separate the ammonia and carbon dioxide from the water.  The only 
possible problems when treating urine would be low water flux through the membrane. 
 Reverse Osmosis 2.4.2.4
During reverse osmosis, the transfer of water is against the osmotic pressure difference across 
the membrane.  This transfer is induced by applying a hydrostatic pressure larger than the 
osmotic pressure on the highly concentrated solution side of the membrane [5].  Reverse 
osmosis has successfully been used to desalinate sea water industrially and in various laboratory 
tests to treat urine [24, 25, 27]. 
The main problem is that the process requires large pressures, and thus high energy 
requirements to achieve the necessary water fluxes across the membranes.  Other problems are 
the poor micro-pollutant retention; and the high sodium chloride retention and scaling, both of 




In electrodialysis, as seen in Figure 5, a current is applied across an electrodialysis stack 
consisting of alternating anion and cation ion-exchange membranes between two electrodes.  
The anion and cation ion-exchange membranes allow passage to only negatively and positively 
charged ions respectively.  The ions move toward the oppositely charged electrode, passing 
through an ion-exchange membrane of opposite charge, but are stopped by the next membrane 
of the same charge.  This movement of ions dilutes the concentrated feed stream while 
producing a concentrated salt solution.   
The process is used in sea water and various other brine desalination processes, and has been 
tested on urine at a laboratory scale.  Electrodialysis can achieve high product purity but works 
most economically on highly concentrated solutions and most effectively on solutions 
containing low molecular weight ionic components [28]. 
 




 Osmotic and Membrane Distillation 2.4.2.6
Osmotic and membrane distillation are two very similar membrane separation processes.  Both 
these processes use hydrophobic membranes with pore sizes between 0.1 and 0.5 μm and 
achieve separation by phase change.  The feed and permeate solutions flow over the membrane 
but due to the membrane being hydrophobic the water cannot pass through in liquid form, 
except if a high enough pressure is exerted.  The water from the feed side then evaporates and 
passes through the pores to the permeate solution.  The driving force for the transfer in osmotic 
distillation is a difference in water activity, caused by the difference in solute concentration 
between the feed and draw solutions at the pores.  In membrane distillation there is an added 
driving force of partial pressure difference induced by heating the feed [30–32]. 
Both these processes have been used in water treatment and desalination [30], and have been 
tested with urine [24, 25].  The problems with these processes are their very low fluxes and the 
requirement for heating in the case of membrane distillation.  The other problem is that there 
may be fouling issues when used with urine. 
 Nanotube Membranes 2.4.2.7
At a very early stage of development, nanotube membranes are membranes made of an array of 
nanotubes orientated perpendicular to an impermeable film [33, 34].  The nanotube membrane 
can be used to desalinate sea water and allows for much higher fluxes than other membranes 
achieving comparable separation [33].  Theses membranes operate with a similar principle to 
porous membranes but the paths the permeate travels offers very little resistance and thus fluxes 
can be much higher.  They have not been tested with urine and the technology must still be 
developed further before this can be done.  
 Biomimetic Membranes 2.4.2.8
Biomimetic membranes attempt to mimic bio-membranes already present in living organisms.  
These membranes are very selective about which chemicals may pass through, and can be 
highly efficient [35, 36].  Biomimetic membranes are still in development and are constantly 
improving.  
Some experiments have been conducted in sea water desalination and the membranes have 




2.4.3 Nitrogen and Ammonia Recovery 
 Ammonia Stripping 2.4.3.1
Stripping is common in the chemical industry as a process to recover a component from a liquid 
by mixing with a vapour and transferring the component to the vapour phase.  The stripping of 
ammonia from urine has been reported in various papers and can achieve around 95% ammonia 
removal from urine [5].  The problem is that the liquid product, 10% ammonia solution, is 
unstable at atmospheric pressure [5]. 
 Anammox Process 2.4.3.2
The Anammox, or anaerobic ammonium oxidation, process is a biological process which 
converts ammonium, nitrites and nitrates to nitrogen gas under anaerobic conditions [5].  This 
process has been tested extensively to treat digester supernatant but few tests on urine have been 
done.  The aim of this process is mainly to eliminate nitrogen from urine and thereby lessen 
possible detrimental effects the nutrients in urine would have on the ecosystem [5].  
The problem is that further processing is required to convert nitrogen to fertiliser and therefore 
it would be more beneficial to produce a product containing a Nitrogen/Phosphorous/Potassium 
(NPK) mixture. 
 Acidification 2.4.3.3
In some cases, it may be necessary to ensure that urea in fresh urine does not hydrolyse.  The 
reasons for this are that urea may be the favoured compound for further reactions or processes 
and is easier to collect, for fertiliser production, than ammonia.  To achieve this, the urine can 
be acidified by adding a strong acid, such as sulphuric acid, to ensure the pH stays below 4, the 
point where the urine begins hydrolysing.  The low pH will also cause deactivation of many 
pathogens and, if low enough, can degrade pharmaceuticals [5]. 
 It is important that the urine is acidified before significant hydrolysis takes place as neutralising 
hydrolysed urine requires approximately four times more acid due to the buffer effect of 
hydrolysed urine, which would drive up costs [5].  Besides the costs and added danger involved 
with purchasing and using the acid, early acidification is strictly required as the urea will begin 
to hydrolyse as it is transported through the pipelines or stored, before reaching the treatment 





Nitrification has been tested extensively for the treatment of high strength industrial waste water 
and animal waste slurries, and has been found to be effective [5].  A few studies have been done 
on the treatment of urine by nitrification [37, 38].  To nitrify urine, oxygen is introduced and 
reacts with the urine in a moving bed biological reactor (MBBR) where the ammonium is 
converted to ammonium nitrate [5].  
Only the MBBR has been found to produce ammonium nitrate, other reactors would produce 
ammonium nitrite, a less preferable chemical for fertilisers.  The resulting solution is stable, 
giving off none of the odour typical of stored urine.  The main problem with this method is that 
only half the nitrogen present in the urine can be converted to ammonium nitrate as the 
nitrification will stop when the pH becomes too low [5]. 
 Struvite Precipitation 2.4.3.5
Magnesium ammonium phosphate (MgNH4PO4.6H2O), also known as struvite, contains 
phosphate and ammonium, two nutrients in urine, and can be used as a slow release fertiliser 
[5].  To form struvite, magnesium is added to hydrolysed stored urine in the form of magnesium 
oxide (MgO), magnesium hydroxide (Mg(OH)2), magnesium chloride (MgCl2), or bittern, the 
magnesium-rich brine formed as a by-product of table-salt production [5].   
The problem with using struvite precipitation in urine is that much of the nitrogen contained in 
the urine is left unrecovered and the urine would have to undergo further treatment to remove 
this [5]. 
 IBDU Precipitation 2.4.3.6
Isobutylaldehyde-diurea (IBDU) is a commercially available, slow release fertiliser.  IBDU can 
be made from urea by adding isobutylaldehyde (IBD).  The urea forms a complex with the IBD 
and precipitates out of solution.  This method could be used to form IBDU from urine but will 
leave a large fraction of urea unconverted as it requires highly concentrated urea to be effective.  
This would mean most of the water contained in the urine would have to be extracted 
beforehand.  The cost of concentrating the urine, and purchasing IBD means that this process 





 Urine Storage 2.4.4.1
The main aim of urine storage for long periods would be to disinfect the urine, deactivating any 
pathogens.  The disinfection is achieved due to the rise in pH during urea hydrolysis resulting in 
the production of ammonia, which is a biocide thereby deactivating pathogens.  The degree of 
disinfection is a function of mainly time, temperature and pH.  The disinfection mechanism is 
the disruption of the cell metabolism by causing a rise in internal cell pH.  This rise in pH is due 
to the travel of various components of urine, especially NH3, into the cell.  This is facilitated by 
the increase in cell membrane permeability due to elevated temperature.  The simplest and 
cheapest way to implement this disinfection method would be the source separation and storage 
of the urine on site.  The now safe urine could then be used directly for fertiliser, although the 
effect of storage on pharmaceuticals must still be investigated; processed on-site; or transported 
via tankers or pipelines for further processing in a treatment plant. 
The most important parameters to take into account when using this method would be, in order 
of greatest effect: temperature, pH and time.  The deactivation rate increases with an increasing 
temperature, with no deactivation below 4°C recorded with storage times below 6 months; and 
increases at pH extremes due to acid dosage or urea hydrolysis.  A suitable temperature of 20°C 
can be easily achieved by underground storage, with no need for temperature control in warmer 
climates [5]. 
The main problem with this disinfection method is the evaporation of ammonia if the tank is not 
properly sealed.  The precipitation could be controlled, while still achieving disinfection, with 
acid dosing [5]. 
 Electrochemical Oxidation of Urea 2.4.4.2
By using a nickel catalyst, the urea in urine can be electrochemically oxidised to form hydrogen, 
nitrogen and carbon dioxide gases [5, 39].  The hydrogen can then be captured for use as fuel.   
This process is still experimental but results have been positive [39] and the collection of 
hydrogen could prove economically viable.  The problems are that all other nutrients are wasted, 






Ion-exchange has been used in waste water treatment to remove unwanted salts.  A complex, 
usually an ion-exchange resin or zeolite, is added to the solution and the desired ions are 
exchanged by attaching to the surface of the complex.   
Ion-exchange has been tested with urine, and clinoptilolite, a naturally occurring zeolite with 
high affinity for ammonium, has been found to be quite effective [5].  The problem with using 
ion-exchange alone is that only the nitrogen would be recovered.  
 Ozonation and Advanced Oxidation 2.4.4.4
Ozonation and advanced oxidation can be used to remove micro-pollutants in waste water and 
has been used experimentally to treat urine [3, 5].  The micro-pollutants are oxidised using 
chlorine, chlorine dioxide, ozone, or hydroxide radicals.  Using this treatment, micro-pollutants 
can be mostly, or completely, removed [5]. The problem is that chemicals must continually be 
added to achieve this.  
 Ultraviolet Treatment 2.4.4.5
Ultraviolet (UV) treatment is used in waste water treatment to deactivate pathogens.  The 
treatment works by exposing the water to ultraviolet radiation which alters the genetic structure 
of bacteria, viruses and other pathogens, rendering them harmless and incapable of 
reproduction [40, 41].  This treatment results in no chlorine or ozone disinfection by-products, 
no chemical residues, and is low risk [41].  
Although this process is frequently used to treat wastewater, it has not been tested on pure urine.  
The main problems with UV treatment include frequent maintenance and replacement of the 
UV lamps, and the need for highly treated feed to ensure no solids are present which could 




2.5 Process Selection 
2.5.1 Treatment Process Analysis 
Table 2 and Table 3 are a qualitative analysis of the information collected during a review of the 
literature available on the various processes.  Table 2 shows all the processing methods 
considered while Table 3 shows the membrane processes in more detail.  These tables and the 
design constraints, provided by the RTTC, will help in the process selection. 
Table 2 took a broad overview and, through a weighting systems, indicates which processes 
were the most promising to compare in further detail in Table 3.  Table 2 covers the following 
sections: 
 Disinfection  
o ability to exclude or inactivate pathogens in urine 
 Water Recovery 
o Indication of the fraction of water recovered, which links to volume reduction 
but focuses on the recovery of water in addition to reducing effluent or 
concentrate volume. 
 Stabilisation 
o Ability to prevent or inhibit urea hydrolysis 
 P, K Recovery 
o Indication of the recovery of phosphorous and potassium in a usable form 
 N Recovery 
o Indication of the recovery of nitrogen in a usable form 
 Micro-pollutant/NPK Separation 
o Ability to separate NPK form micro-pollutants, such as pharmaceuticals and 
compounds naturally excreted in urine, such as creatinine. 
 Micro-pollutant Elimination 
o Ability to breakdown micro-pollutants. 
Once the most promising technologies had been identified, a more in depth comparison was 
undertaken, summarised in Table 3.  This table follows a similar format to Table 2 with a 
weighting system geared toward finding technologies that will achieve a split between the NPK 
and the unwanted components, namely pathogens, micro-pollutants and sodium chloride.  In 
addition, some important design considerations are represented which helped to provide a better 




















VCD 2 3 2 3 3 1 1 [5, 12, 42] 
TIMES 2 3 2 3 3 1 1 [5, 14] 
AES 2 3 2 3 3 1 1 [5] 
Multi-stage Flash 3 3 2 3 3 1 1 [5] 
Freeze-thaw 2 2 1 3 3 1 1 [5] 
Solar Evaporation 3 2 2 3 3 1 1 [16, 18, 43, 44] 
Passarell Process 3 2 2 3 3 1 1 [19, 20] 
Membrane 
Membrane Distillation 4 2 1 4 4 4 1 [24, 25, 30, 31] 
Reverse Osmosis 4 3 1 3 3 4 1 [5, 24, 25] 
Forward Osmosis 4 3 1 3 3 4 1 [23–26] 
Electrodialysis 3 2 2 2 2 2 1 [5, 28, 39] 
Micro/Ultra Filtration 2 1 3 1 1 1 1 [5, 21] 




Ammonia Stripping 1 2 1 1 3 3 1 [5] 
Anammox Process 2 1 3 1 1 2 1 [5] 
Acidification 2 1 3 1 1 1 1 [5] 
Nitrification 2 1 3 1 1 1 1 [5, 37, 38] 
Struvite 1 3 1 3 3 3 1 [5] 
IBDU Precipitation 1 2 1 1 3 2 1 [5] 
Other 
Ion-Exchange 1 2 1 1 3 2 1 [5] 
Advanced Oxidation 2 1 2 1 1 1 4 [5] 
UV Treatment 4 1 3 1 1 1 4 [40, 41] 
Storage 2 1 1 1 1 1 2 [5] 
Table 2: Processing Methods 
No effect or Not Feasible / Low Some Effect / Medium Strong Effect / High Most Effect / Very High 
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Reverse Osmosis Forward Osmosis Microfiltration Ultrafiltration Nanofiltration 
Pathogen Removal 4 4 4 2 2 3 
Enzyme/Microbe Rejection 1 1 1 3 3 1 
P, K Retention 4 3 3 1 2 3 
Urea Retention 4 3 3 1 1 2 
Micropollutant/P, K Separation 1 1 1 1 2 1 
Micropollutant and Pharmaceuticals 
Rejection 
4 4 4 1 1 4 
Requirement for pre-treatment 2 4 3 1 1 3 
Flux (actual value in brackets) [l/m
2
.h] 1 3 (20) 2 (12) 4 4 4 (100) 
Available Literature 2 2 3 1 1 2 
Extent Tested on Urine 2 2 2 2 2 3 
Energy Required [kWh/m
3
 water] 2 1 (24) 2 (6) 4 (0.3) 3 2 (6) 
Primary energy source Heat Pressure Heat Pressure Pressure Pressure 
Cost 2 3 2 1 2 2 
Simplicity of System 3 4 2 1 2 3 
Requirement for Chemical Addition 1 2 1 1 1 1 
Nutrient Product Stream Usability 3 3 3 1 1 2 
Product Water Stream Quality 4 3 3 1 1 2 
References [24, 25, 30, 31] [5, 24, 25] [23–26] [5, 21] [5, 21] [5, 22] 
Table 3: Membrane Processes 
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2.5.2 Design Constraints 
The main design constraints for the urine treatment section of the system, taken from the design 
constraints from the RTTC requirements, include: 
 Energy requirements 2.5.2.1
Energy is often one of the largest costs of any industrial plant and so every effort should be 
made to use energy optimally.  The RTTC toilet systems have to be designed to be self-
sufficient and so minimising energy usage is vital.  One of the best ways to achieve this is to use 
readily available energy sources.  The main energy source in the proposed system could be low 
grade heat, for example from the combustion of faeces.  Thus any process that could utilise this 
energy, and does not require high calorific energy usage, high electricity usage or high 
pressures, is preferable. 
According to this constraint, the following processes are unfavourable: 
 Electrodialysis      → high electricity 
 Lyophilisation       →high electricity 
 Vapour Compression Distillation   → high electricity 
 Passarell Process     → high calorific/electricity 
 Multi-stage Flash     → high electricity 
 Air Evaporation System     → high calorific energy 
 Reverse Osmosis      → high pressure 
 Minimal Consumables 2.5.2.2
Many processes require the addition of chemicals to function correctly.  These chemicals may 
be reagents, catalysts or some type of inhibitor.  Regardless of the purpose, the chemicals would 
have to be bought and dosed correctly, which would require skilled technicians to ensure correct 
operation.  Both the purchasing and monitoring would increase operating costs.  Minimising 
consumables is therefore a good way of lowering operating costs.  
According to this constraint, the following processes are unfavourable: 
 Struvite precipitation      → chemical addition 
 IBDU precipitation     → IBD addition 
 Ozonation and Advanced oxidation   → ozone addition 
 Acidification      → acid addition 
 Ion Exchange      → chemical addition 
 Thermoelectric Integrated Membrane Evaporation → chemical addition 




 Robust and Modular System 2.5.2.3
The treatment system will be installed in remote areas and would function largely autonomously 
and thus should be low maintenance and easily repairable.  The units should be easy to replace, 
and be robust enough to handle varying feeds and possibly regular start-ups and shut-downs.  
Thus, biological systems, which are feed specific and do not handle large flow changes, and 
systems which are technologically complex or new, should be avoided. 
According to this constraint, the following processes are unfavourable: 
 Anammox Process      → biological system 
 Biological reduction of nitrates    → biological system 
 Thermoelectric Integrated Membrane Evaporation → technologically complex 
 Ultra-violet treatment      → technologically complex 
 Nanotube membranes      → new technology 
 Biomimetic membranes     → new technology 
 Universal Applicability 2.5.2.4
The last constraint is that the system must be able to function in varying climates and 
geographies as the system is meant for global use.  This means that relying on a specific 
resource from an area, such as plentiful direct sunlight, is undesirable.   
According to this constraint, the following processes are unfavourable: 
 Solar evaporation 
2.5.3 Urine Treatment Process Selection 
Once various processes are disregarded due to not adhering to the design constraints of the 
RTTC, the result is that a combination of membrane processes, excluding electrodialysis, 
nanotube and biomimetic membranes, seems to be a promising solution.  Table 3, in 
section 2.5.1, shows a summary of the information gathered regarding the various viable 
membrane processes.  To decide on which processes to select, the primary aims of the system 
must be considered.  These are: pathogen removal; separation of phosphorous, potassium and 
nitrogen sources from sodium chloride; minimal energy usage; and the production of water 
suitable for irrigation.  Using Table 3 and the stated aims, various membrane process 
configurations are possible with a combination of microfiltration, nanofiltration and forward 











Organics, Pharmaceuticals, Large Salts
Forward Osmosis / Membrane Distillation
 
Figure 6: Process Flow Diagram 1 
The first approach, shown in Figure 6, would concentrate the urine by separating the water from 
the urine, possibly using a combination of forward osmosis and membrane distillation.  The aim 
behind this was to concentrate all the nutrients into one stream making fertiliser production 
easier.  The problem with this process flow would be the potential of significant fouling at the 
first stage, as all the organics and salts would still be present. Lower flux across the membrane 
due to fouling would lead to lower recovery rates and higher energy requirements. 
 
(2) Primary separation of waste components, secondary separation of water and brine 
Forward Osmosis / Membrane Distillation
Urine Water, Some Salts





Figure 7: Process Flow Diagram 2 
The second approach, shown in Figure 7, would decrease the fouling potential at the first stage 
by using a nanofiltration membrane, which is more resistant to fouling.  The benefits of the 
scheme would be the concentration of the desired salts for fertiliser production in one stream.  
The problem with the second process would come with the separation after the nanofiltration 




(3) Removal of potential fouling components, secondary separation of waste 
components, tertiary separation of water and brine 








Figure 8: Process Flow Diagram 3 
The third approach, shown in Figure 8, uses three different membrane units in series.  The first 
stage – microfiltration (MF) or loose ultrafiltration (UF) - acts as a screening step to remove 
organic components which could cause fouling downstream.   
According to literature [22], nanofiltration is capable of rejecting at least: 80 % of micro-
pollutants; 95 % of the phosphate; 70 % of the potassium; and 65 % of the ammonia.  Urea, 
which made up the bulk of the total nitrogen, has a rejection rate of around 10%.  The 
concentrate from the NF stage, containing the nutrients phosphorous and potassium, will be sent 
for further processing, for instance the combustion unit dealing with solid waste, to deactivate 
the micro-pollutants before being used to make fertiliser.  A final forward osmosis (FO) stage 
(or combination of forward osmosis and membrane distillation) separates the remaining salts 
from water.   
The whole process should be able to accept the various feed solutions that might flow into the 
urine processing unit within the toilet - including fresh and stored urine, as well as urine 
contaminated with faecal matter. 
2.6 Nanofiltration 
As the remainder of the study focuses on nanofiltration, as reasoned in Section 2.7, further 
literature on nanofiltration is detailed in this section. 
2.6.1 Definition 
Nanofiltration is a membrane operation which separates a feed stream into a permeate stream, 
containing material which has passed through the membrane, and a retentate stream, containing 
the components rejected by the membrane.  By using a membrane operation, a solvent-solute 
solution or solid-liquid suspension can be concentrated or purified and a solute-solute mixture 
can be fractionated [46]. 
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Some of the advantages of using membrane operations to effect a separation are as follows [46]: 
 Separation can take place at ambient, or near ambient temperature, without a net phase 
change.  This saves energy compared with separation processes which require phase 
change to occur, requiring a heat input. 
 Membrane operations are well suited to continuous operation, and need only be washed 
if fouling layers form and lower flux below acceptable levels.  
 No chemicals are required to effect the separation.  This means that products will not 
contain additional pollutants or contaminants and consumable costs for operation 
decrease. 
2.6.2 Separation Mechanism 
Nanofiltration membrane operations use a combination of three different separation mechanisms 
to affect the separation.  The mechanisms involved are as follows: size exclusion or sieve-effect, 
dominant when the molecular weight of the solute is much greater than the Molecular Weight 
Cut-off (MWCO), which is a measure of the molecular weight of a compound above which it 
would be 90 % rejected by the membrane; solution-diffusion and electrostatic interaction [47], 
which is unique to nanofiltration and dominant when the molecular weight of the solute is much 
lower than the MWCO [48].   
The sieve-effect excludes compounds based on their size in relation to the pore size of the 
membrane and the driving force for the separation is an induced pressure difference.  This is 
usually characterised by the MWCO of the membrane.  However, this is by no means a 
definitive measure of rejection potential as many compound rejections do not follow this trend 
[47].  A better measure of this mechanism, although harder to quantify, would be pore size 
distribution or effective number of pores, and membrane porosity [47].   
The operation of the sieve-effect is also influenced by: the hydrophobicity of the membrane and 
molecules, with MWCO being overestimated for hydrophilic molecules and underestimated for 
hydrophobic molecules of the same size [49]; and the surface morphology of the membrane, 
with discrete small-pore structure giving a better membrane selectivity [49].  
The solution-diffusion mechanism achieves separation based on the solubility and diffusivity of 
the compounds and the permeability of the membrane.  Transport takes place in the free volume 
of the membrane between the macro-molecular chains of the material [46] and is induced by the 
concentration difference between the permeate and retentate.  Operating temperature plays a 
role in solution-diffusion, with an increase in temperature causing an increase in convective 
flux, diffusivity of molecules and water flux, thereby reducing retention [49]. 
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The significant influence of electrostatic interactions, between molecules and between 
molecules and membrane, on the rejection performance is unique to nanofiltration and can 
heavily influence the rejection of ions.  Most nanofiltration membranes have a negative charge, 
due to the sulphonic or carboxylic acid groups in the membrane deprotonating at neutral pH.  
This is why negative molecules will be better rejected than neutral and positive molecules of 
comparative size [49].   
The relationship between membrane surface charge and pH also means that the charge will 
change with pH, with an increase in pH leading to a larger negative charge and therefore an 
increase in rejection, of negatively charged molecules.  In addition to the pH affecting the 
membrane charge, it may also influence the dissociation state, orientation and solubility of the 
solutes.  By changing a solute dissociation state, the rejection of the solute can be changed.  
Lastly, the ionic strength of the solution influences rejection by increasing the relative pore size 
of the charged membrane pores which results in a rejection decrease, particularly of monovalent 
ions [49]. 
Based on the nanofiltration mechanisms and the pore size of the membranes, this process can be 
used to remove salts, hardness or minerals, pathogens, turbidity, disinfection by-product 
precursors, synthetic organic compounds, pesticides and other water contaminants [46].  
Although not all contaminants can be removed using nanofiltration, it has the potential to 
remove a wider range of contaminants than many other treatment technologies [46]. 
2.6.3 Membrane Types 
Synthetic nanofiltration membranes can be manufactured from a large number of materials but 
can be classed as either organic or inorganic.   
Organic membranes are manufactured using polymers.  Many types of polymers can be used to 
manufacture the membranes but, due to difficulties in processing, economic considerations and 
membrane durability, only a few are used in practice.  The most widely used polymers are 
cellulose and its derivatives, due to their low cost and low absorption tendency [46].  These 
polymers make hydrophilic membranes which are used in all pressure driven membrane 
operations as well as haemodialysis and gas permeation [46].   
Cellulose ester membranes, although sensitive to acid or alkaline hydrolysis, are relatively 
resistant to chlorine, temperature and biological degradation, making them popular in water 
treatment [46].  These membranes should transfer well to treating a highly saline solution such 




Polyamide membranes, which are hydrophilic and more chemically, thermally and 
hydrolytically stable than cellulose membranes, are also used in water treatment, although these 
membranes are highly sensitive to oxidative degradation and cannot tolerate chlorine even in 
trace quantities [46]. 
Inorganic membranes generally have greater chemical, mechanical and thermal stability relative 
to organic membranes. The disadvantages to these membranes are their high cost and brittle 
nature.  The main materials used in inorganic membrane manufacture are ceramics, including 
oxides, nitrides or carbides of various metals [46]. 
2.6.4 Fouling 
An important factor during NF membrane operation is the reduction in permeate flow due to 
fouling.  There are three causes of fouling in pressure driven membrane processes: 
 Cake Formation 2.6.4.1
Cake formation occurs when the material rejected by the membrane accumulate on the 
membrane surface.  The resistance to permeation of this cake layer can be quite significant and 
will increase with decreasing particle size [46].  Cake fouling can be reduced by increasing the 
cross-flow velocity of the solution across the membrane, in an attempt to carry any caking 
material away, as well as by pre-treating the feed to remove fouling agents [46]. 
 Precipitative Fouling 2.6.4.2
Precipitative fouling or scale formation occurs when the salt concentration near the membrane 
surface is higher than the salt solubility.  The concentration of the salts increases either, because 
of the increase of the bulk concentration of the salts as a result of the removal of water from the 
solution, or because of concentration polarisation.  The latter refers to the concentration gradient 
between the boundary layer near the membrane surface and the bulk of the feed solution, due to 
the selective permeation of ions through the membrane causing a build-up of the rejected ion 
species [46].  Controlling precipitative fouling usually involves using anti-caking agents, dosing 
the feed with acid to control anionic species concentration or pre-treating the feed to remove 




 Adsorptive Fouling 2.6.4.3
Adsorptive fouling occurs when materials are deposited inside the membrane pores.  This 
fouling is especially prevalent with feed solutions containing organic materials, can have a 
much greater effect on flux than other fouling, and is usually very difficult to remove [46].  
There are three main ways to reduce adsorptive fouling.  First, negatively charged membranes 
with a high surface charge density, associated with membrane hydrophilicity, can be used.  
Second, solution pH can be increased, as lower pH tends to favour adsorption.  Last, the 
membranes can be cleaned with a caustic and enzymatic chemical wash, which can re-dissolve 
the adsorbed organic compounds [46]. 
2.6.5 Nanofiltration of urine 
As mentioned, published data regarding nanofiltration in conjunction with urine is quite scarce.  
Pronk et al. [22] dealt with the ability of nanofiltration membranes to remove pharmaceuticals 
found in urine and is a primary reference for this study.  The use of nanofiltration to remove 
pharmaceuticals is quite common in the water treatment systems but has not been used before 
with pure urine.  Pronk et al. posited that, by passing urine through a nanofiltration membrane, 
the permeate stream would be a nutrient rich and micro-pollutant free liquid suitable for use as 
an agricultural fertiliser.   
Although the focus was on micro-pollutant removal, tests were done on the retention of various 
salts necessary for the permeate stream to be used as fertiliser.  The researchers started with 
three different membranes with varying fresh water permeability and molecular weight cut-offs.  
The membranes were the NF 270 by Dow-Filmtec, the NF 30 by Microdyn-Nadir and the DS 5 
by Osmonics.  After testing the membranes, it was decided to focus on the NF 270 as this 
membrane gave the most desirable rejections profile for the involved nutrients.  A detailed 
breakdown of the rejections by the NF 270 membrane, for both synthetic and fresh urine, can be 
found in Figure 9.  Most importantly, the urea rejection is never higher than 20 %, the 
phosphate and sulphate are almost entirely rejected at all pH values, sodium and potassium have 
similar rejections usually around 60 % and the ammonia rejection varies widely with pH, 
between 5 and 65 %.  Unfortunately, the paper does not go into detail regarding the pressures, 





Figure 9: Fresh and synthetic urine rejections from Pronk et al. [22] 
The majority of the remaining publications in this field were from a modelling perspective.  
These papers attempt to formulate a suitable model for mixed salt solutions, which reverse 
osmosis models cannot adequately represent due mainly to the electrostatic interactions that take 
place during nanofiltration.  The most useful models would be those that represent a mixed salt 
solution with ions present in urine, such as sodium, chloride, phosphate, nitrates and potassium.  
Many of the papers, through experiments attempting to validate the proposed models, can 
provide information regarding rejection for various ions through a selection of membranes. 
Four different research papers [50-53] have been published which contained experimental work 
concerning solutions containing more than three ions, some or all of which are present in urine.  
Three of them [50–52] detail effort into developing a model specifically for nanofiltration of 
mixed salt solutions containing 3 or more ions.  The research uses the same experimental setup 
and conditions in each paper, with three different nanofiltration membranes and various salts to 
test the model.  The membranes used were the ESNA 1, ESNA 1-LF and LES 90 membranes 
made by the Nitto Denko Corporation. These papers give the details of only some of the 
experimental conditions, namely: membrane area; mean pore radius; pure water permeability; 
feed concentrations and flux of the solutions.  Some of the important variables left out include 
the solution pH and temperature, the cross-flow rate or tangential velocity, and the pressure 
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Although some important variables are left out, the results are still useful in presenting the 
rejection for the membranes.  Figure 10 shows results from the three papers, with marker colour 
indicating the various solution compositions and marker shape indicating membrane.  The 
results indicate that the rejection of the various ions can vary by as much as 20 % just by 
changing the solution composition, as indicated by the sodium rejection rates.  The rejection 
rates for all ions were quite high compared to the other papers, all being around 75 % and 
higher.  The researchers were able to accurately model the transmission rates of the ions, with 
errors of between 10 and 20 % for the various ions modelled, including solutions containing 
multivalent ions.  Still to be investigated is the effect permeation flux and pH have on the 
accuracy of the model. 
 
Figure 10: Salt solution rejections from Wang et al. [50–52] 
Hayryen et al. [53] carried out a study concerning the concentration of mine water by 
nanofiltration and reverse osmosis.  The research only used one nanofiltration membrane, as 
reverse osmosis was found to be better suited to their requirements, and details the pH, 
temperature, tangential velocity, cross-flow velocity, membrane area and flux but gives no 
information about the membrane pore size or MWCO and pure water permeability.  The data 
from the studies [50-53] is summarised in Figure 11.  The figure shows the rejections of several 
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Figure 11: Summary of Experimental Results [22, 50–53] 
In order for a nanofiltration step to be useful in the treatment system, there must be a separation 
between the unwanted compounds and the desired nutrients in the urine.  From the literature, it 
can be seen that the rejection of many of the ions shown vary considerably. Through Figure 9, 
Figure 10 and Figure 11, it seems that a favourable set of conditions may exist where the 
possibility of waste and nutrient separation exists.   
To achieve this, either: most of the sodium chloride in the urine must be retained, which is 
possible with rejection as high as 97%, while allowing nitrogen passage, which would be 
possible with urea rejection consistently below 20% for fresh urine; or, depending on the 
sodium chloride limits in fertiliser, there must be sufficient sodium chloride permeation through 
the membrane with retention of sufficient phosphate and nitrogen, from hydrolysed urea, to 
produce a retentate economically and agriculturally viable for processing into fertiliser.  
As there are many variables affecting the rejection of ions, a model of the ion permeation would 
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2.7 Gap Analysis 
The membrane system chosen in section 2.5.3 must be designed to (i) separate components as 
desired; (ii) achieve a sufficient level of throughput and (iii) not use excessive amounts of 
energy.  The following design data are required to achieve this: 
- Expected compositions of different urine feeds (fresh, aged, contaminated with faecal 
material) 
o Data on segregated fresh and aged urine is readily available [7] but the 
possibility of faecal contamination in the toilet must still be accounted for. 
- Fouling and reduction in fouling after cleaning 
o No data was found in the literature on fouling for membrane processes used 
with a urine feed.  An investigation into the use of a forward osmosis process 
for the desalination of sea water found that fouling rates were low, due to low-
pressure operation, but greater fouling rates would be expected with a urine 
feed [26, 45]. 
- Recovery of water and rejection of solutes 
o Microfiltration is commonly used to treat waste water instead of granular media 
filtration combined with ozone treatment units [21].  Using microfiltration to 
remove particulates from urine is likely to be effective but no data has been 
found in the literature on rejection of organic particulates with a pure urine 
feed.  
o The use of nanofiltration with fresh and synthetic urine feeds has been 
investigated and showed potassium and phosphate rejections of 65 % and 95 % 
respectively, and various pharmaceutical compound rejections upwards of 80 % 
at a pH of 5 [22].  There were very few specifications given, regarding the 
operating conditions required to achieve this separation, and only fresh urine 
and synthetic fresh urine were tested.  
o Production of potable water from sea water [23, 26, 45] and waste water using 
forward osmosis is well documented, with water recovery of up to 70 %, salt 
rejections of 95 % and fluxes up to 25 l/m
2
.h [23], but the use of forward 
osmosis for urine treatment has not been widely studied.  A few papers [24, 25] 
using forward osmosis with urine feed indicate that there are some promising 





- Flux through the membranes 
o The flux through the forward osmosis stage will be the rate limiting factor to 
the process. 
o According to one paper flux in the NF stage is expected to increase with pH but 
no further specifics were given [22]. 
The knowledge gaps in the use of nanofiltration for urine treatment are seen as the most 
pertinent missing information as achieving the required salt separation is a key factor in all three 
proposed configurations.  Therefore, the remainder of this work focuses on nanofiltration, 




3 MATERIALS AND METHODS 
As stated in section 2.6.1, the focus of the experimental section of the project was on 
nanofiltration.  Through quantitative experimental analysis, the salt rejections’, reported in 
section 2.6.5, were checked for repeatability.  Then the results of the experiments were used to 
determine if it is possible to retain the majority of the valuable minerals, including potassium, 
phosphorous and nitrogen, while allowing permeation of sodium chloride in hydrolysed urine. 
3.1 Research Design 
The experiments used two different solutions to investigate the focus area of the salt split 
through nanofiltration.  The solutions consist of: a synthetic solution developed by 
Udert et al. [11] which is seen as an accurate approximation of completely hydrolysed urine; 
and fully hydrolysed urine, which has been in storage for over 6 months.  In Table 4 below the 
composition of the synthetic urine is detailed.  In the case microfiltration was chosen as pre-
treatment, it would have been ideal to pass the stored urine through a rigorously defined 
microfiltration system beforehand but time did not permit this and so fouling was expected to be 
higher than necessary. 
Substance Mass Vol. Conc. Moles 
  [g] [ml] [g/mol] [mol] 
Na2SO4 anhydrous 9.2   142.0 0.06 
NaH2PO4 anhydrous 8.4   120.0 0.07 
NaCl 14.4   58.4 0.25 
KCl 16.8   74.6 0.23 
NH4Ac 38.4   77.1 0.50 
NH4OH solution (25% NH3)   52 22.3 2.33 
NH4HCO3 85.6   79.1 1.08 
H2O Distilled   4000 18.0 222.04 




List of chemical names: 
Na2SO4 anhydrous Anhydrous Sodium Sulphate 
NaH2PO4 anhydrous Anhydrous Sodium Dihydrogen Phosphate 
NaCl Sodium Chloride 
KCl Potassium Chloride 
NH4Ac Ammonium Acetate 
NH4OH solution (25% NH3) Ammonium Hydroxide Solution 
NH4HCO3 Ammonium Bicarbonate 
H2O Distilled Distilled Water 
 
The membranes used were 3 different DOW-Filmtec membranes, the NF270, NF90 and XLE 
membranes, as these are easily obtainable and are in widespread commercial use.  According to 
the membrane characteristics given by the supplier, their performance and quality are of 
acceptable levels.  Another reason to use DOW-Filmtec membranes is that the NF 270 
membrane was used in the work of by Pronk et al. [22], discussed in the literature review, which 
enabled a direct comparison of the results with the same membrane.  The membranes have 
MWCOs ranging from 100 to 400, with XLE having the smallest and NF 270 the largest, and 
are made of polyamide.  This type of membrane is frequently used in wastewater and brine 




3.2 Experimental Design 
This section details the nanofiltration rig, experimental procedure and the analytical equipment. 
3.2.1 Nanofiltration Equipment 
Figure 12 on page 40 illustrates the high-pressure membrane-testing unit. 
The high pressure cross-flow membrane laboratory set-up consisted of 3 cells in series, each 
containing a flat sheet membrane with a 38 mm diameter, held in place by a sintered steel disc.  
The equipment can reach pressures gradients across the membrane cells of up to 6000 kPa, 
equivalent to a transmembrane pressure (TMP) of 3000 kPa, and a maximum flow rate of 
around 3 l/min.  The individual cell area was 0.0011 m
2
 and the feed channels had a cross-
sectional area of 9.82 mm
2
, resulting in a cross-flow velocity of about 1.698 m/s at a flow of 1 
l/min.  
The feedstock was pumped from the feed tank, which has a 20 l capacity and can be heated or 
cooled via a coil, and fed into the cells.  The permeate stream from each cell was sent to a 
sample container (cylinders 1 – 3), where the mass was recorded.  The retentate was sent to the 
next cell in series and was fed back to the feed tank after the third cell, with the flow rate 








































Figure 12: High Pressure Cross-flow Membrane Laboratory Rig 
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The pressure drop could be measured across the cells using 2 pressure gauges with accuracies of 
± 3%, one for lower pressure readings up to 2500 kPa and the other for reading up to 6000 kPa.  
The pressure drop across the cells and the flow rate were controlled using a combination of 
opening the valve on the return line and the pump speed.  The reflux valve was used for rapid 
changes in flow rates, and thereby pressures, and also served as a means to reduce hydrostatic 
shock across the membranes during start-up and shutdown.  
3.2.2 Experimental Procedure 
The procedure for conducting the experiments was as follows: 
1) The mass of water passing through each of the clean membranes was measured, at 5-minute 
intervals over a period of 20 minutes, with a constant cross-flow velocity.  This was done at 
four TMPs, namely 375, 500, 625 and 750 kPa.  The mass measurements along with the 
density of water and the membrane area allowed for the calculation of the water flux. 
2) Similarly, the flux of the two solutions, synthetic urine and stored urine, were calculated.  A 
fresh membrane was used each time and the tests used a constant retentate flow of 1.6 l/min 
at a pressure of 800 kPa, with 15 minute intervals over a period of 45 minutes.  This was 
done for both the NF 270 and NF 90 membranes.  The salt rejections were calculated from 
these samples using the equipment detailed in section 3.2.3. 
3) The same procedure was followed for the XLE membrane but the TMP was increased after 
each interval starting at a TMP of 800 kPa, increasing to 1000 kPa and finally 1250 kPa.  
The time interval between each measurement was 20 minutes to allow sufficient volume for 
analysis.  This increase in TMP allowed for further analysis of membrane behaviour. 
4) Lastly the water flux experiment, detailed in point 1, was repeated for each of the used 
membranes.  The difference in flux allowed for an analysis of the fouling caused by the 
solutions. 
3.2.3 Analytical Equipment 
Evaluating the membrane performance requires the calculation of the rejections.  To do this the 
concentrations of the various elements and ions in the feed and permeate were analysed.  The 




 Spectroquant Nova 60 3.2.3.1
The Spectroquant Nova 60 is a spectrophotometer, which uses the absorbance of light by the 
solution to calculate the concentration of the ions present.  To do this, specific wavelengths of 
light, in this case from a tungsten-halogen lamp, are passed through the test solution.  The 
solution would absorb only certain wavelengths of light depending on the substances present.  
The concentration of the substance will affect the loss of intensity of the light passing through 
the solution.  This is characterised by the transmittance, denoted by T, shown in Equation 3[55]: 
𝐓 =  𝐈 𝐈𝟎
⁄  
Equation 3: Transmittance 
𝐼 = 𝑖𝑛𝑡𝑒𝑛𝑡𝑖𝑠𝑡𝑦 𝑜𝑓 𝑡ℎ𝑒 𝑡𝑟𝑎𝑛𝑠𝑚𝑖𝑡𝑡𝑒𝑑 𝑙𝑖𝑔ℎ𝑡 
𝐼0 = 𝑖𝑛𝑡𝑖𝑎𝑙 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑡ℎ𝑒 𝑙𝑖𝑔ℎ𝑡  
Where intensity is measured in lux (lx) or lumens per square meter (lm/m
2
). 
However, the concentration is generally determined using the absorbance, denoted by A.  This 
is the measure of the light absorbed and is used as the absorbance correlates directly with 
concentration of the absorbing substance.  Equation 4 shows the relationship between the 
absorbance and transmittance: 
𝐀 = − 𝐥𝐨𝐠𝐓 
Equation 4: Absorbance 
The concentration can be calculated by using the measured transmittance and the Beer-Lambert 








Equation 5: Absorbance, Concentration relationship 
𝑖 = 𝑐ℎ𝑒𝑚𝑖𝑐𝑎𝑙 𝑠𝑝𝑒𝑐𝑖𝑒𝑠 
𝜀𝑖 = 𝑀𝑜𝑙𝑎𝑟 𝑎𝑡𝑡𝑒𝑛𝑡𝑢𝑎𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 (
𝑚2
𝑚𝑜𝑙⁄ ) , 𝑠𝑝𝑒𝑐𝑖𝑒𝑠 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡  
𝑐𝑖 = 𝑀𝑜𝑙𝑎𝑟 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (
𝑚𝑜𝑙
𝑙⁄ )  




Knowing the expected concentration range of the desired species enables the preparation of the 
sample so that the Nova 60 can accurately measure the intensity of the transmitted light.  This 
preparation uses reagents to convert the species to be measured into a coloured compound and 
includes masking agents that reduce the interference of other ions in absorbing light at the 
specific wavelengths used.  The Nova 60 will then calculate the concentration of the selected 
species.  Section 8.2.1 details this procedure for various species.   
A limited number of testing kits for the Nova 60 were available and therefore the tests were 
limited to one pressure per membrane for each of the solutions.   
 Agilent 4100 MP-AES 3.2.3.2
The Agilent 4100 MP-AES is a Microwave Plasma – Atomic Emission Spectrometer.  In 
general, an atomic emission spectrometer (AES) allows for the calculation of the concentration 
of specific elements by measuring the intensity of light emitted at a wavelength particular to 
each element.  This emission is the result of atoms at an excited energy state releasing their 
energy when moving back to their ground energy states.  The way in which the atoms achieve 
this excited state differs for each type of AES.  These include using a flame, inductively coupled 
plasma, and electric arc or in this case microwave energy.  The industrial magnetron charges 
nitrogen plasma with microwave energy and this is then used to excite the atoms of the sample.  
When the excited atoms return to the ground state the emitted light is split by a prism and 
detected by a spectrometer. [56] 
The 4100 MP-AES is capable of measuring the concentration of a wide range of metals as well 
as phosphorous, silicon and sulphur accurately and the measurements for each element are not 
as prone to spectral interference from other elements as other AES methods, such as inductively 
coupled plasma AES (ICP-AES) machines. [56]  
The ion concentrations measured by the Nova 60 were of total nitrogen, ammonium and 
chloride.  The element concentrations measured by the 4100 MP-AES were phosphorous, 
potassium and sodium.   
 Other 3.2.3.3
The pH of the solution was measured using pH strips, resulting in an accuracy of ±0.5.  The 
conductivity of the permeate streams could not be measured using the available conductivity 




3.3 Data Analysis 
3.3.1 Transport Model 
Solute flux can be calculated directly using the water flux and solute concentration: 
𝑱𝒊 = 𝑱𝒘𝑪𝒊,𝑷 
Equation 6: Solute Flux from Water Flux 
But can also be calculated using the definition of flux; the mass of solute moving across the 








Equation 7: Solute Flux 
𝑚 = 𝑚𝑎𝑠𝑠 𝑓𝑙𝑜𝑤𝑟𝑎𝑡𝑒 
𝐴 = 𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒 𝑎𝑟𝑒𝑎 
The solute rejection can be calculated using permeate and feed concentrations, by Equation 8: 




Equation 8: Solute Rejection 
𝐶𝑖,𝑃 = 𝑝𝑒𝑟𝑚𝑒𝑎𝑡𝑒 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑠𝑜𝑙𝑢𝑡𝑒 𝑖 
𝐶𝑖,𝐹 = 𝑓𝑒𝑒𝑑 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑠𝑜𝑙𝑢𝑡𝑒 𝑖 
Rearranging Equation 8 to solve for permeate concentration gives: 
𝑪𝒊,𝑷 = 𝑪𝒊,𝑭(𝟏 − 𝑹𝒊) 
Equation 9: Solute Concentration in Permeate 
Equating Equation 6 and Equation 7 and replacing the solute permeate concentration with 






= 𝑱𝒘𝑪𝒊,𝑷 = 𝑱𝒘𝑪𝒊,𝑭(𝟏 − 𝑹𝒊) 
Equation 10 





= 𝑱𝒘𝑪𝒊,𝑭(𝟏 − 𝑹𝒊)𝑨 
Equation 11: Solute Mass Flowrate 
The water flux is a function of the TMP and is effected by fouling, but can be assumed constant 








Equation 12: Water Flux at constant TMP 
𝑉 = 𝑓𝑒𝑒𝑑 𝑣𝑜𝑙𝑢𝑚𝑒 





Equation 13: Transmembrane Pressure 
𝑃𝐹 = 𝑓𝑒𝑒𝑑 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 
𝑃𝑅 = 𝑟𝑒𝑡𝑒𝑛𝑡𝑎𝑡𝑒 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 
𝑃𝑃 = 𝑝𝑒𝑟𝑚𝑒𝑎𝑡𝑒 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 
3.3.2 Effect of Membrane Area 
The flow of solute from the feed to the permeate would decrease the solute concentration in the 
feed over time.  Although this change is negligible for this system, due to the small permeate 
flowrate compared to the feed volume, the effect can be shown by increasing the area in the 
above model   
3.3.3 Water Recovery 
A high water recovery is vital for the nanofiltration treatment to be viable.  Having a good split 
between the NPK and Na does no good if this only happens at low water recoveries as this 
would mean most of the nutrients would be carried off in the retentate.  Equation 14 is used to 
calculate the water recovery. 
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𝑊𝑎𝑡𝑒𝑟 𝑅𝑒𝑐𝑜𝑣𝑒𝑟𝑦 =  
𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 − 𝐹𝑖𝑛𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟
𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟
 
Equation 14: Water Recovery 
3.3.4 Separation Factors 
A good way to show the split between the different ions is to calculate the separation factors.  
These factors clearly show the degree to which the species are rejected by the membrane with 













Equation 15: Separation Factor 
A low separation factor (<1) shows that the membrane will reject species ‘i’ to a greater degree 
than species ‘j’ and a high separation factor shows the opposite.  The further from 1 the 
separation factor is the larger the split will be between the two species.  If the separation factor 
is equal to 1, this means there is no difference in the rejection of component ‘i’ or ‘j’.  
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4 RESULTS AND DISCUSSION 
The main objectives of this project, as stated in section 1.3, were to place membrane processes 
in the context of urine treatment, identify the knowledge gaps which prevent the usage of 
membrane systems for urine processing, and lastly to explore critical knowledge gaps for the 
use of nanofiltration through experimentation.  The first two objectives have been addressed in 
the literature review and the subsequent analysis, and the last objective is explored here.  
The specific knowledge gaps, identified in section 2.6.1 and specified in detail in section 3.1, 
can be summarised as follows:  verifying salt rejections reported in literature and determining if 
it would be possible to retain the majority of the valuable minerals, including potassium, 
phosphorous and nitrogen, while allowing permeation of the undesired sodium chloride in 
hydrolysed urine. 
4.1 Analytical Equipment 
This section details findings for this project relating to the analytical equipment used to measure 
the samples.  Included will be any concerns regarding the precision and accuracy of the 
measurements and how these were dealt with. 
4.1.1 Spectroquant Nova 60 Operation 
The Nova 60 has a few limitations when taking measurements.  Firstly, the test kits are only 
available for selected species and for a specific concentration range.  The concentration of the 
sample can be diluted to fall into this range but this introduces the possibility of dilution errors 
which are difficult to detect and prove when only one sample is prepared per sample taken.  
Second, as mentioned above, when measuring for one species another species may interfere 
with the readings if the concentration of the interfering species is too high for the masking 
agents to deal with.  This was not a problem during this project as the appropriate kits were 
selected as the probable stream compositions were known and the actual compositions of 
interfering species was checked again once readings were done.  Lastly, the Nova 60 relies on 
the sample being solids free for accurate concentration readings.  Due to the samples coming 
from nanofiltration permeate this was not an issue. 
For accurate measurements it is important to regularly calibrate the Nova 60, ensure that the 
species likely to interfere with the species being measured are within acceptable concentrations, 
carefully follow the preparation procedure for the various test kits and ensure that the sample 
cells are properly cleaned.  In addition, multiple preparations of each sample would be ideal, 
however due to cost of test kits this is prohibitive.   
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During test work the readings of each prepared sample was repeated three times.  These samples 
were prepared using dilution factor between 20 and 100, which accounts for the measurement 
ranges discussed being lower than the actual sample concentrations.  The precision for these 
readings was excellent for the samples with lower concentrations, below 10 mg/l, and fairly 
good for higher concentrations, 10 to 100 mg/l.  The precision can be found through first 
calculating the standard deviation of the repeated measurements of the same sample, the 
standard deviation can then be compared to the detection range.  The standard deviations 
calculated this way were as follows: 0.1 mg/l for 0-5 mg/l, 0.578mg/l for 5 – 10 mg/l, 1.57 mg/l 
for 10-30 mg/l and 3.46 mg/l for 30-70 mg/l. 
4.1.2 Analytical Precision 
 
































Figure 14: Initial Concentration of Stored Urine 
Table 5: Stored and Synthetic Urine Composition and Analytical Precision 
Urine Type  N Cl NH4 K P Na 
USU Average 3067 2644 1668 1907 440 2224 
 S. Dev. 252 793 227 106 37 63 
 % Error 8 30 14 6 9 3 
Stored Average 3183 1106 2667 790 1617 2162 
 S. Dev. 104 142 289 42 50 135 
 % Error 3 13 11 5 3 6 
 
In an attempt to quantify the precision of the sample preparation and measurement method 
together, the initial measurements from each membrane run was compared on a per element 
basis for both the synthetic urine, Figure 13, and stored urine, Figure 14.  These figures show 
the precision of both the Nova 60, which measured the nitrogen, ammonium and chloride, and 
the Agilent 4100, which measured the sodium, potassium and phosphorous.  The measurements 
for each element should be the same if the analysis procedure was precise.  As seen from the 
figures, this was not the case.   
The easiest way to compare this error over the various concentration ranges was to use the 
standard deviation of the measurements and then take this as a percentage of the average value 
for that element.  The results, shown in Table 5, shows that the measurements for the synthetic 





























species in the stored urine caused less interference during measurements than the limited, but 
more concentrated, chemicals in the synthetic solution.  The table also shows that the Agilent 
4100 is generally more precise than the Nova 60.  This makes sense as the preparation 
procedure for the Nova 60 is more complex than the dilution necessary for the Agilent 4100. 
4.2 Flux Results 
4.2.1 Water Flux versus Transmembrane Pressure 
The first step in the experimental phase was to find the clean water flux with varying 
transmembrane pressure for each of the membranes.  This would allow a comparison to the 
water flux after the synthetic and stored urine had been passed through the membrane.  This 
comparison would give an indication of the fouling potential of the two solutions. 
 
Figure 15: Water flux vs transmembrane pressure for the 3 membranes 
As seen in Figure 15, the transmembrane pressure was varied from 375 kPa to 750 kPa and 
followed the expected trend of flux increasing with increasing membrane MWCO.  The trend 
also shows that the flux increases with increasing transmembrane pressure.  This follows the 
typical models for flux vs TMP, with a linear region proportional to the TMP, a transitional 
region, where most of the data points fall, and the mass transfer controlled region approached 
around the 800 kPa mark in these cases.  The data for Figure 15 ca be found in Table 8, Table 7 






















NF 270 NF 90 XLE
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These plots also indicate that the membranes should be operated at a TMP of between 400 and 
500 kPa for most efficient energy use, as in this region a change in flux is still proportional to a 
change in TMP.  However, higher TMPs were chosen to ensure a high enough flux so that the 
operating time for the trials was reasonable.  During industrial scale-up the choice of TMP will 
be a trade-off between the capital cost (CAPEX) due to the membrane size and the operating 
cost (OPEX) of increasing the TMP.  In this case a higher CAPEX would be preferable due to 
the requirement for a low energy system. 
4.2.2 Synthetic and Stored Urine Fluxes 
 
Figure 16: Average Synthetic and Stored urine flux for 3 membranes, at a TMP of 800 kPa 
As seen in Figure 16, based on Tables 16-28, at a TMP of 800 kPa and flow rate of 1.6 l/min the 
synthetic urine flux is lower than the stored urine flux.  It was expected that the stored urine flux 
would be lower as the fouling was expected to be higher than the fouling caused by the 
synthetic urine.  This seemed the likely case as the synthetic was made of laboratory grade 
ingredients while the stored urine contained organics and particulates, however this is not the 
case.  The lower flux for the synthetic urine could be due to the osmotic pressure difference 
between the synthetic and stored urine.  The synthetic urine has a higher osmotic pressure due to 




















Synthetic Urine Flux Stored Urine Flux
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Another unexpected result was the higher flux for the stored urine through the XLE membrane 
than through the NF 90 membrane, while the synthetic urine and water flux follow the opposite 
trend.  This may be due to the difference in chloride concentration between the stored and 
synthetic urine, 1100 vs 2600 mg/l, and the NF90 having a higher rejection of chloride ions. 
 
Figure 17: Flux vs Time at constant TMP 
Figure 17 shows the water flux over time at constant TMP for the NF270 and NF90 membranes 
with both stored and synthetic urine.  Generally, the plots follow a similar pattern, increasing 
over time before levelling off.  This suggests that there is some initial period where the 
membrane changing before reaching a steady state, perhaps absorbing a certain amount of 
molecules before becoming saturated. 
4.2.3 Solution Flux versus Transmembrane Pressure 
To gauge the behaviour of the solution flux with varying transmembrane pressure, this was 
varied from 800 kPa to 1250 kPa during the experiments with the XLE membrane.   The results 
obtained at a flow rate of 1.6 l/min, as seen in Figure 18, show a trend of increasing flux with 
transmembrane pressure.  Interesting to note is that this trend differs from that seen with clean 
water and varying TMP in Figure 15, here the plot is still quite linear, although the flux is 
significantly lower.  This suggests that a higher operating TMP is possible before the 


























Figure 18: Synthetic and stored urine Flux vs TMP for XLE membranes 
4.2.4 Fouling Potential 
An important factor to consider when operating membrane systems is the degree to which the 
membrane can be fouled by the feed solutions.  This could lead to drastically reduced flux, 
which would mean that the transmembrane pressure or more likely the membrane surface area 
would have to be increased to account for this decrease, which will lead to an increase in energy 
requirements.  The fouling potential of the synthetic and stored urine is shown in Figure 19.  
This potential was determined by comparing the water flux through each of the membranes 
before and after nanofiltration experiments.   
It can be seen that the degree of fouling increased with decreasing MWCO of the membranes.  
The flux difference on the NF 270 membrane was negligible, while the difference in the NF 90 
and XLE membranes was quite noticeable.  The only outlier is the flux in the XLE membrane 
used with the stored urine, where the water flux after running the urine through the membrane 
was higher than the water flux through a clean membrane.  This illogical result was most likely 



























Figure 19: Water flux through the 3 membranes, before and after filtration 
4.3 Rejection Results 
4.3.1 Rejections by Membrane Type 
According to Figure 20, which shows the rejections for the synthetic urine solution and the 
stored urine, there is a wide range of rejections for the various ions.  Generally, rejection 
increases with decreasing MWCO, from NF 270 to NF 90 to XLE, as expected.   
The first exception to this was for chlorine, where the XLE membrane had the lowest rejection, 
presumably due to electrostatic forces playing a more significant role here than in the other 
membranes.  The second exception was for phosphorous, where the XLE membrane again had a 
lower rejection than the other membranes but was close enough to be caused by experimental 
error, within 10% for the stored urine.    
The ammonium rejection results were rather peculiar, with opposite trends for the stored and 
synthetic urine.  However, the measurements had high standard deviations and if it were 










































Ion or Element 
NF 270 - Synthetic NF 270 - Stored
NF 90 - Synthetic NF 90 - Stored
XLE - Synthetic XLE - Stored
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4.3.2 Rejection vs Transmembrane Pressure 
The rejections for varying TMP, shown in Figure 21, were conducted using the XLE membrane 
and TMPs of 800, 1000 and 1250 kPa.  Generally, the observed rejections increased with an 
increase in the transmembrane pressure, which is expected as the driving force for the water flux 
relies on the transmembrane pressure while the driving force for salt passage relies on the 
concentration difference across the membrane.  The rejections of the other ions were 
approximately the same with changing transmembrane pressure but the inaccuracy in the 
measurements, as seen by the error bars, indicate more experiments with varying 
transmembrane pressure need to be conducted. 
 



















XLE - Synthetic - Potassium XLE - Stored - Potassium
XLE - Synthetic - Sodium XLE - Stored - Sodium
XLE - Synthetic - Phosphorous XLE - Stored - Phosphorous
XLE - Synthetic - Nitrogen XLE - Stored - Nitrogen
XLE - Synthetic - Chloride XLE - Stored - Chloride
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4.3.3 Comparison to Literature 
Comparing the average rejections reported by Pronk et al. [22], shown in Figure 22, to those 
experimentally found with the NF 270 membrane show similar rejections for ammonium but 
rejections were found to be lower for phosphorous, sodium, chloride and potassium at a 
transmembrane pressure of 800 kPa.   
 
Figure 22: Literature Rejections and Experimental Rejections for NF 270 membrane 
Using the increase in rejection with an increase in TMP found when using the XLE membrane it 
is possible to reach slightly higher rejections.  However, it seems highly unlikely that the 
phosphorous rejection found by Pronk et al. [22] would be achievable using the NF270. 
4.4 Nanofiltration Usage 
In summary the flux of each of the membranes was found suitable for industrial application and 
fouling resulted in negligible decrease in flux for the NF 270 membrane, a 15 % decrease in flux 
for the NF 90 and an 18 % decrease for the XLE membrane, which is within the tolerable limits.   
However, the rejection profiles of the membranes do not seem promising for use in the intended 
system as the split between nitrogen and sodium and potassium and sodium was not sufficient.  
Other membranes may produce more positive results but perhaps resources would be better 
spent by considering incorporating a nitrogen recovery process in conjunction with a 

















Element of Ion 
NF 270 Average Rejection - Pronk et al. NF 270 Average Rejection - Experimental
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4.5 Transport Model 
A simulation was run using the model laid out in section 3.3.1 on the NF90 membrane using the 
synthetic urine composition.  The aim of the simulation was to vary the membrane area to 
determine the effects on water recovery, separation factors, and feed and permeate 
concentrations.  The results of this investigation are presented in this section. 
4.5.1 Effect of increasing membrane area on feed concentration  
From Figure 23, it can be observed that there is a marked increase in the solute concentrations 
on the feed as the membrane area was increased. 
 
Figure 23: Concentration of species on the feed side 
* It must be noted that this plot was done by Mr Brouckaert as part of a summary of various projects falling under the 
Bill & Melinda Gates Foundation. Explanation and interpretation of plot by the author of this thesis. 
The increase in solute concentration indicates that the water flux was increasing much faster 
than solute flux. Even though the water flux remained unaltered, the volume of water moving 
across the membrane increased because the membrane area was larger.  
4.5.2 Effect of increasing membrane area on permeate concentration 
The solute concentration on the permeate side also increased when the membrane area was 
increased. This can be seen in Figure 24. 
 















































Figure 24: Concentration profile of species on permeate side 
* It must be noted that this plot was done by Mr Brouckaert as part of a summary of various projects falling under the 
Bill & Melinda Gates Foundation. Explanation and interpretation of plot by the author of this thesis. 
4.5.3 Water recovery 
The system used is designed to have a low water recovery so that the assumption of negligible 
volume change is valid.  So with a membrane surface area of only 0.0011m
2
 the water recovery 
ranged from 0.12% for the NF90 membrane to 2% for the NF270 membrane. Using the 
transport model detailed in section 3.3.1 the area was increased by multiplying the initial area 
by 10 and 50, the recovery increased to 10% and 52% respectively for the NF90 membrane with 
the synthetic urine. 
  












































Figure 25: Concentration profile as a function of water recovery for NF90 with synthetic urine 
* It must be noted that this plot was done by Mr Brouckaert as part of a summary of various projects falling under the 
Bill & Melinda Gates Foundation. Explanation and interpretation of plot by the author of this thesis. 
Figure 25 shows the concentration of solute species with increasing water recovery based on the 
transport model. It should be noted that the concentrations in Figure 25 represents the solute 
concentrations at the end of 45 minutes.  The concentrations of all species increased with 
increasing water recovery.  This is expected but not ideal for the sodium.  The increase in 
sodium concentration will have to be weighed against the water recovery when deciding the 
operating point for full-scale operation.  
4.5.4 Separation factors 
When choosing the base species for the separation factor it is most useful to choose a species 
that is desired and has a high rejection to better show if the desired split between the species is 
taking place.  For this reason, the separation of the other ions was measured relative to the 
phosphate ion.  Figure 26 shows the separation factors of various ions, relative to the phosphate 




Figure 26: Separation factors relative to the phosphate ion for NF90 with Synthetic Urine 
* It must be noted that this plot was done by Mr Brouckaert as part of a summary of various projects falling under the 
Bill & Melinda Gates Foundation.  Explanation and interpretation of plot by the author of this thesis. 
Figure 26 shows clearly that there is an excellent separation between phosphate and sodium 
ions, with a separation factor over 3.25.  There is excellent separation and between the 
ammonium and sodium ions, as ammonium has a separation factor near 0.5.  The separation 
between total nitrogen and sodium is reasonable, with a difference in separation factor of 1, but 
that the potassium ions tend to pass through the membrane at a similar degree to the sodium 
ions, having similar separation factors.  A slight increase in the separation factors for sodium, 
potassium, chlorine and nitrogen is observed at high water recoveries, suggesting a greater split 





The outcome of this project was twofold: firstly, to explore the use of membrane systems, 
within the current and potential processes for the treatment of urine in the context of the Re-
invent the Toilet Challenge; secondly, to identify and explore knowledge gaps necessary for the 
implementation of such a membrane system, focussing specifically on the NF membrane stage.   
The first outcome was performed by researching the reasons for treating urine and the processes 
currently in use, as well as those that may be used in future to treat urine and waste water and as 
well as for desalination.  There are seven objectives for the treatment of urine, namely 
disinfection, volume reduction, stabilisation, phosphorous, nitrogen recovery, nutrient removal 
and micro-pollutant removal.  The processes that can be considered for achieving these 
objectives can be broken down into 4 major categories, namely membrane filtration, 
evaporation, nitrogen and ammonia recovery and others.  When assessing the treatment 
processes available, using the literature analysis along with the guidelines set in the RTTC, a 
combination of different membrane filtration units seemed to be an extremely promising path to 
pursue. 
This finding lead to identifying three promising membrane separation scenarios, which could be 
used for the recovery of valuable materials from urine, all three involving nanofiltration 
separation.  The most promising scenario was chosen and the scarcity of specific operating 
parameters and separation potential of the nanofiltration membrane was identified as the key 
knowledge gap.  An experiment was designed, involving the nanofiltration of synthetic and 
stored urine through 3 different polyamide Dow-Filmtec NF membranes with MWCOs between 
100 and 400.  This experiment would determine whether a NF could achieve the required 
separation of the NPK from the sodium chloride.  The separation of NPK from sodium chloride 
is important as sodium chloride inhibits plant growth.  The findings lead to several conclusions: 
 The precision of the Nova 60 was not as high as anticipated, with Cl- and NH4+ 
measurements being particularly problematic with errors between 10 and 30 %. 
 The flux achieved by the membranes, 80 – 100 l/m2.h for NF 270, 6 – 8 l/m2.h for 
NF 90, and 4 – 10 l/m
2
.h for XLE, followed the order of the MWCO. 
 The flux would be sufficient for the RTTC purposes and was similar to literature values. 
 The flux was still increasing with increasing TMP between 800 and 1250 kPa for the 
XLE membrane, indicating that higher TMP conditions are usable without loss of 
energy efficiency. 
 Fouling resulted in negligible decrease in flux for the NF 270 membrane, a 15 % 
decrease in flux for the NF 90 and an 18 % decrease for the XLE membrane, which is 
within the tolerable limits.  
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 and the lowest 
for Cl
-
, suggesting electrostatic forces influencing rejection. 







, which suggests that this membrane may be the most useful if phosphorous 
recovery was of primary importance. 
 The rejections of all species save phosphorous was consistently lower with the synthetic 
urine as opposed to the stored urine.  In the case of phosphorous this can be explained 
by the stored urine having a much higher concentration than the synthetic. 
 The rejections of all species increases with increasing water recovery and there would 
be a trade-off between water recovery and sodium retention in the NP rich retentate. 
 The transport model suggests a high separation between phosphorous and sodium and 
ammonium and sodium, this was supported for phosphorous by previous work in 
literature but not during these trials.  Neither literature nor these trials support the 
transport model with the ammonium/sodium split.  
 These results suggest that perhaps using nanofiltration membranes for the recovery of 
phosphorous in conjunction with a second type of technology for the recovery of 





The project fulfilled the research outcomes set out in section 1.3, however there are a number of 
recommendations for future research in the area of membrane systems, in particular 
nanofiltration, and urine: 
 Perform more experiments with this set of membranes to obtain a larger set of results so 
that a more accurate model can be fitted. 
 Perform experiments with membranes of different membrane material which may 
provide a more beneficial separation between the desired and undesired salts. 
 Investigate the impact of temperature and pH on rejections in order to attempt to 
achieve the desired separation. 
 Consider incorporating the membrane system with a nitrogen recovery method such as 
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8.1 Urine Composition 
8.1.1 Fresh Urine 









8.2 Analysis Equipment 
8.2.1 Spectroquant Nova 60 SOPs 
Standard Operation Procedure – Ammonium 
Test 
  (Cat. No. 1.00683)  
1. Scope and Field of Application 
Test measures both ammonium ions and dissolved ammonia in a concentration range of 2 – 150 
mg/l NH4-N 
2. Principle 
Ammonium nitrogen (NH4-N) occurs partly in the form of ammonium ions and partly as 
ammonia. A pH-dependent equilibrium exists between the two forms.  In strongly alkaline 
solutions NH4-N is present almost entirely as ammonia, which reacts with hypochlorite ions to 
form monochloramine. This in turn reacts with a substituted phenol to form a blue indophenol 
derivative that is determined photometrically. 
3. Interferences 
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Fe
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 25   NaCl 20% 
Hg
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Mg
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 Analyze immediately after sampling. 
 Preferably collect samples in glass bottles. 
 The pH must be within the range 4 - 13. Adjust, if necessary, with sodium hydroxide or 
sulfuric acid. 
 Filter turbid samples. 
 Check the ammonium content with the Merckoquant Ammonium Test. Samples 
containing more than 150 mg/l NH4-N must be diluted with distilled water. 
 
5. Safety Precautions 
 Handle concentrated acid with care 
 Always use safety goggles, gloves, and laboratory coat while working in laboratory  
 After the analysis clean the bottles and beakers with distilled water before for drying 
 Dispose any used gloves after completion of analysis 
 Clean hands using antiseptic soap and disinfect with ethanol solution 
 Avoid spillage and contact with skin.  In the latter case wash with copious amounts of 
cold water and call for medical attention. 
6. Apparatus 
 Spectroquant 
 Pipettes for pipetting volumes of 0.10, 0.20, and 5.0 ml 
 Rectangular cells 10 mm (2 pcs), Cat. No. 114946 
7. Reagents 
 Reagent NH4-1 
 Reagent NH4-2 (contains granulate + desiccant capsule) 
 Merckoquant® Ammonium Test, Cat. No. 110024 
 Universal indicator strips pH 0 - 14, Cat. No. 109535 
 Sodium hydroxide solution 1 mol/l  
 Sulfuric acid 0.5 mol/l  
8. Calibration 





Measuring range of 2.0 – 75.0 mg/l NH4-N (2.6 – 96.9 mg/l NH4+): 
1. Pipette 5.0 ml of reagent NH4-1, stored between 20 – 30 °C, into a test tube 
2. Pipette 0.2 ml of pretreated sample into the test tube and mix. 
3. Add 1 level blue microspoon of reagent NH4-2 and shake vigorously until the reagent is 
completely dissolved. 
4. Leave to stand for 15 minutes, in a test tube rack, then fill the sample into a 10 mm cell 
and measure in the photometer. 
Measuring range of 5 – 150 mg/l NH4-N (6 – 193 mg/l NH4+): 
1. Pipette 5.0 ml of reagent NH4-1, stored between 20 – 30 °C, into a test tube 
2. Pipette 0.1 ml of pretreated sample into the test tube and mix. 
3. Add 1 level blue microspoon of reagent NH4-2 and shake vigorously until the reagent is 
completely dissolved. 
4. Leave to stand for 15 minutes, in a test tube rack, then fill the sample into a 10 mm cell 
and measure in the photometer. 
Notes on the measurement: 
 Reclose the reagent bottles immediately after use. 
 Due to the strong temperature dependence of the colour reaction, the temperature of the 
reagents should be between 20 and 30 °C. 
 Ensure the cells are cleaned, with dry paper towel, for the photometric analysis. 
 Measurement of turbid solutions yields false-high readings. 
 Ammonium-free samples turn yellow on addition of reagent NH4-2. 
 The pH of the measurement solution must be within the range 11.5 - 11.8. 
 The colour of the measurement solution remains stable for at least 60 min after the end 
of the reaction time stated above. 
 In the event of ammonium concentrations exceeding 2500 mg/l, other reaction products 
are formed and false-low readings are yielded. In such cases it is advisable to conduct a 
plausibility check of the measurement results by diluting the sample (1:10, 1:100) 
10. Data Quality 
Measurement 2 – 75 mg/l NH4-N 5 – 150 mg/l NH4-N 
Standard Deviation (mg/l NH4-
N) 
± 0.49 ± 1.0 
Confidence Interval (mg/l 
NH4-N) 
± 1.2 ± 2 
Sensitivity (mg/l NH4-N) 0.3 1 
Accuracy (mg/l NH4-N) ± 1.8 ± 4.0 
11. Chemical Waste Disposal 
 Rinse glassware ammonium-free with distilled water, do not use detergent. 
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Standard Operation Procedure – Chloride Test 
(Cat. No. 1.14897) 
1. Scope and Field of Application 




Chloride ions react with mercury(II) thiocyanate to form slightly dissociated mercury(II) 
chloride. The thiocyanate released in the process in turn reacts with iron(III) ions to form red 
iron(III) thiocyanate that is determined photometrically. 
3. Interferences 
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4. Sampling 
 Preferably collect samples in glass bottles. 
 Analyze immediately after sampling.  
 The pH must be within the range 1 - 12. Adjust, if necessary, with dilute ammonia 
solution or nitric acid. 




5. Safety Precautions 
 Handle concentrated acid with cares 
 Always use safety goggles, gloves and laboratory coat while working in laboratory  
 After the analysis clean bottles and beakers with water keep it for drying 
 Dispose the used gloves after completion of analysis 
 Clean hands using antiseptic soap  
 Disinfect hands after washing with soap 
 Avoid spillage and contact with skin.  In the latter case use copious washings with cold 
water and call for medical attention. 
6. Apparatus 
 Spectroquant 
 Pipettes for pipetting volumes of 0.50, 1.0, 2.5, and 5.0 ml 
 Rectangular cells 10 mm (2 pcs), Cat. No. 114946 
 Universal indicator strips pH 0 - 14, Cat. No. 109535 
7. Reagents 
 Reagent Cl-1 
 Reagent Cl-2 
 Nitric acid for 1 mol/l 
 Ammonia solution 25% 
8. Calibration 
To check the photometric measurement system (test reagent, measurement device, and 
handling) and the mode of working, chloride solutions, 12.5 mg/l Cl
-
, and 125 mg/l Cl
-






1. Pipette 5 ml, for 2.5 – 25 mg/l Cl-, or 1 ml, for 10 – 250 mg/l Cl-, of pretreated sample 
into test tube. 
2. Pipette 2.5 ml of reagent Cl-1 into tube and mix. 
3. Pipette 0.5 ml of reagent Cl-2 into tube and mix. 
4. Leave to stand for 1 min, then fill the sample into a 10 mm cell.  
5. Measure in the photometer. 
Notes on the measurement: 
 Analyze immediately after sampling. 
 Reclose the reagent bottles immediately after use. 
 For photometric measurement the cells must be clean. Wipe, if necessary, with a dry 
paper towel.  
 Measurement of turbid solutions yields false-high readings. 
 The pH of the measurement solution must be approx. 1. 
 The color of the measurement solution remains stable for 30 min after the end of the 
reaction time stated above. (After 60 min the measurement value would have increased 
by 5 %.) 
10. Data Quality 
Measurement 2.5 – 25.0 mg/l Cl
-
 10 – 250 mg/l Cl
-
 
Standard Deviation (mg/l Cl
-
) ± 0.19 ± 2.8 
Confidence Interval (mg/l Cl
-
) ± 0.5 ± 7 
Sensitivity (mg/l Cl
-
) 0.3 1 
Accuracy (mg/l Cl
-
) ± 1.0 ± 10 
 
11. Chemical Waste Disposal 





Standard Operation Procedure – Nitrogen (Total) 
Cell Test 
(Cat. No. 1.14763) 
1. Scope and Field of Application 
Test measures the total nitrogen, in a concentration range of 10 – 150 mg/l N, of solutions with 
a maximum of 2% sodium chloride. 
2. Principle 
Organic and inorganic nitrogen compounds are transformed into nitrate according to Koroleff’s 
method by treatment with an oxidizing agent in a thermoreactor. In a solution acidified with 
sulfuric and phosphoric acid, this nitrate reacts with 2,6-dimethylphenol (DMP) to form 4-nitro-
2,6-dimethylphenol that is determined photometrically. 
3. Interferences 















































 1000   
When the quantity of reagent N-1K is doubled, the tolerable COD increases ``to 7000 mg/l. In 
the event of higher COD values false-low results are obtained. 
 
4. Sampling 
 Preferably collect samples in glass bottles. 
 Analyze immediately after sampling.  
 Check, where necessary, the COD with the Spectroquant® COD Cell Test. In the event 
of COD values of more than 7000 mg/l, the sample must be diluted with distilled water. 




5. Safety Precautions 
 Handle concentrated acid with cares 
 Always use safety goggles, gloves and laboratory coat while working in laboratory  
 After the analysis clean bottles and beakers with clear water keep it for drying 
 Dispose the used gloves after completion of analysis 
 Clean the hands using antiseptic soap  
 Disinfect hands after washing with soap 
 Avoid spillage and contact with skin.  In the latter case use copious washings with cold 
water and call for medical attention. 
6. Apparatus 
 Spectroquant 




 Reagent  N-1K 
 Reagent N-2K 
 Reagent N-3K 
8. Calibration 
To check the photometric measurement system (test reagent, measurement device, and 
handling) and the mode of working, nitrogen (total) solutions, 10.0 mg/l N, and 100 mg/l N can 
be used. 
9. Procedure 
6. Pipette 1 ml of pretreated sample into an empty cell. 
7. Add 9 ml of distilled water into cell and mix. 
8. Add 1 level blue microspoon of reagent N-1K and mix. 
9. Add 6 drops of reagent N-2K, close cell and mix. 
10. Heat the cell at 120 °C in the preheated thermoreactor for 1 hour. Shake the cell briefly 
after 10 minutes. 
11. Pipette 1 ml of the digested solution into a reaction cell. Do not mix. 
12. Pipette 1 ml of reagent N-3K the reaction cell, close the cell and mix. Wear eye 
protection and hold the cell only at the top. 
13. Leave the hot reaction to stand for 10 min (reaction time). Do not cool with water. 




Notes on the measurement: 
 Analyze immediately after sampling. 
 Reclose the reagent bottles immediately after use. 
 For photometric measurement the cells must be clean. Wipe, if necessary, with a dry 
paper towel.  
 The colour of the measurement solution remains stable for 30 min after the end of the 
reaction time stated above. (After 60 min the measurement value would have increased 
by 5 %.) 
10. Data Quality 
Measurement 10 – 150 mg/l N 
Standard Deviation (mg/l N) ± 1.1 
Confidence Interval (mg/l N) ± 3 
Sensitivity (mg/l N) 2 
Accuracy (mg/l N) ± 5 




8.3 Result Sheets 
8.3.1 Water Flux 
Time Vial Mass of measuring vial [g] Pressure Retentate Flow Flow Flux 
 s   Initial Final Net Average Average Variance ml/min l/m
2
.h 
0         375 1.15 0.02     
300 1A 16.68 19.86 3.17 375 1.2 0.02 0.63 58 
600 2A 16.79 19.98 3.20 375 1.25 0.02 0.64 59 
900 3B 16.43 19.60 3.16 375 1.26 0.02 0.63 58 
1200 4A 16.25 19.37 3.12 375 1.28 0.02 0.62 57 
1500 5A 16.60 19.72 3.12 375 1.28 0.02 0.62 57 
1800 1B 16.66 19.79 3.13 375 1.3 0.02 0.63 57 
                0.63 58 
0         500 1.2 0.02     
300 1A 16.69 20.62 3.94 500 1.18 0.02 0.79 72 
600 2A 16.79 20.69 3.90 500 1.2 0.02 0.78 72 
900 3B 16.44 20.32 3.89 500 1.2 0.02 0.78 71 
1200 4A 16.25 20.08 3.83 500 1.2 0.02 0.77 70 
1500 5A 16.60 20.40 3.80 500 1.2 0.02 0.76 70 
1800 1B 16.66 20.41 3.75 500 1.2 0.02 0.75 69 
                0.77 71 
0         625 1.12 0.02     
300 1A 16.68 21.14 4.46 625 1.12 0.02 0.89 82 
600 2A 16.78 21.14 4.36 625 1.15 0.02 0.87 80 
900 3B 16.44 20.74 4.30 625 1.15 0.02 0.86 79 
1200 4A 16.26 20.48 4.22 625 1.15 0.02 0.84 77 
1500 5A 16.60 20.98 4.38 625 1.15 0.02 0.88 80 
1800 1B 16.66 20.93 4.27 625 1.15 0.02 0.85 78 
                0.87 79 
0         750 1.14 0.02     
300 1A 16.68 21.19 4.51 750 1.14 0.02 0.90 83 
600 2A 16.79 21.24 4.45 750 1.2 0.02 0.89 82 
900 3B 16.43 20.86 4.43 750 1.25 0.02 0.89 81 
1200 4A 16.24 20.58 4.56 750 1.25 0.02 0.91 84 
1500 5A 16.61 20.94 4.34 750 1.27 0.02 0.87 80 
1800 1B 16.66 20.99 4.33 750 1.27 0.02 0.87 79 
                0.89 82 




Time Vial Mass of measuring vial [g] Pressure Retentate Flow Flow Flux 
 s   Initial Final Net Average Average Variance ml/min l/m
2
.h 
0         375 1.2 0.02     
300 1A 16.69 23.70 7.02 375 1.32 0.02 1.40 129 
600 2A 16.79 23.88 7.09 375 1.36 0.02 1.42 130 
900 3B 16.47 23.41 6.94 375 1.42 0.02 1.39 127 
1200 4A 16.28 23.25 6.97 375 1.43 0.02 1.39 128 
1500 5A 16.62 23.57 6.95 375 1.45 0.02 1.39 127 
1800 1B 16.67 23.50 6.83 375 1.45 0.02 1.37 125 
                1.39 128 
0         500 1.38 0.02     
330 1A 16.68 25.75 9.06 500 1.28 0.02 1.65 151 
630 2A 16.79 25.14 8.35 500 1.32 0.02 1.67 153 
930 3B 16.44 24.57 8.13 500 1.35 0.02 1.63 149 
1230 4A 16.25 24.20 7.95 500 1.38 0.02 1.59 146 
1530 5A 16.61 24.47 7.87 500 1.38 0.02 1.57 144 
1830 1B 16.66 24.53 7.87 500 1.38 0.02 1.57 144 
                1.61 148 
0         625 1.34 0.02     
300 1A 16.68 25.41 8.72 625 1.34 0.02 1.74 160 
600 2A 16.79 25.41 8.62 625 1.34 0.02 1.72 158 
900 3B 16.44 25.06 8.62 625 1.34 0.02 1.72 158 
1200 4A 16.25 24.70 8.45 625 1.34 0.02 1.69 155 
1500 5A 16.60 25.12 8.51 625 1.34 0.02 1.70 156 
1800 1B 16.66 25.18 8.52 625 1.34 0.02 1.70 156 
                1.71 157 
0         750 1.28 0.02     
300 1A 16.69 25.65 8.97 750 1.28 0.02 1.79 164 
600 2A 16.79 25.72 8.94 750 1.29 0.02 1.79 164 
900 3B 16.43 25.15 8.72 750 1.3 0.02 1.74 160 
1200 4A 16.25 24.78 8.75 750 1.28 0.02 1.75 161 
1500 5A 16.66 25.79 9.13 750 1.34 0.02 1.83 168 
1800 1B 16.60 24.79 8.19 750 1.35 0.02 1.64 150 
                1.74 160 
0         875 1.33 0.03     
360 1A 16.68 27.35 10.67 875 1.33 0.03 1.78 163 
660 2A 16.79 25.68 8.90 875 1.33 0.03 1.78 163 
960 3B 16.43 25.23 8.79 875 1.33 0.03 1.76 161 
1260 4A 16.25 25.01 8.76 875 1.33 0.03 1.75 161 
1560 5A 16.60 25.42 8.82 875 1.33 0.03 1.76 162 
1860 1B 16.66 25.26 8.60 875 1.33 0.03 1.72 158 
                1.76 161 




Time Vial Mass of measuring vial [g] Pressure Retentate Flow Flow Flux 
 s   Initial Final Net Average Average Variance ml/min l/m
2
.h 
0         375 1.05 0.02     
300 1A 16.68 20.22 3.53 375 1.07 0.02 0.71 41 
600 2A 16.79 20.38 3.59 375 1.1 0.02 0.72 42 
900 3B 16.43 19.99 3.55 375 1.08 0.02 0.71 41 
1200 4A 16.25 19.82 3.57 375 1.15 0.02 0.71 42 
1500 5A 16.60 20.23 3.63 375 1.17 0.02 0.73 42 
1800 1B 16.66 20.26 3.61 375 1.17 0.02 0.72 42 
                0.72 42 
0         500 2.1 0.02     
300 1A 16.69 21.60 4.92 500 2 0.02 0.98 57 
600 2A 16.79 21.71 4.92 500 2 0.02 0.98 57 
900 3B 16.44 21.39 4.96 500 2.15 0.02 0.99 58 
1200 4A 16.27 21.26 5.00 500 2.22 0.02 1.00 58 
1500 5A 16.60 21.50 4.90 500 2.08 0.02 0.98 57 
1800 1B 16.66 21.71 5.06 500 2.25 0.02 1.01 59 
                0.99 58 
0         625 2.15 0.02     
300 1A 16.68 22.67 5.98 625 2.2 0.02 1.20 70 
600 2A 16.79 22.68 5.89 625 2.15 0.02 1.18 69 
900 3B 16.43 22.43 6.00 625 2.2 0.02 1.20 70 
1200 4A 16.25 22.20 5.95 625 2.2 0.02 1.19 69 
1500 5A 16.60 22.50 5.90 625 2.24 0.02 1.18 69 
1800 1B 16.66 22.54 5.88 625 2.25 0.02 1.18 69 
                1.19 69 
0         750 1.28 0.02     
300 1A 16.69 23.53 6.85 750 1.28 0.02 1.37 80 
600 2A 16.78 23.46 6.67 750 1.29 0.02 1.33 78 
900 3B 16.44 23.11 6.68 750 1.3 0.02 1.34 78 
1200 4A 16.25 22.84 6.82 750 1.28 0.02 1.36 80 
1500 5A 16.60 23.32 6.72 750 1.34 0.02 1.34 78 
1800 1B 16.66 23.23 6.57 750 1.35 0.02 1.31 77 
                1.34 78 
Table 9: XLE Distilled Water Permeability 
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8.3.2 Synthetic Urine 
Membrane NF 270 Units Time [min] 
Solution Synthetic 
 
0 15 30 45 
Pressure Average kPa 1600 1600 1600 1600 
 
Variance kPa 50 50 50 50 
Retentate Flow Reading l/min 1.6 1.6 1.6 1.6 
 
Variance l/min 0.02 0.02 0.02 0.02 
Mass Total g 29.13 35.22 35.89 36.79 
 
Cell g 14.02 14.01 13.83 14.00 
 
Net g 15.11 21.20 22.06 22.78 
Permeate Flow  ml/min 
 





76.79 79.88 82.51 
Table 10: Experimental data of synthetic urine run through NF 270 membrane 
Substance Reference Net 
  [g] [ml] [g/mol] [mol] [g] [ml] [mol] 
Na2SO4 anhydrous 9.2   142.0 0.06 9.206   0.06 
NaH2PO4 anhydrous 8.4   120.0 0.07 8.409   0.07 
NaCl 14.4   58.4 0.25 14.404   0.25 
KCl 16.8   74.6 0.23 16.804   0.23 
NH4Ac 38.4   77.1 0.50 38.4   0.50 
NH4OH solution (25% NH3)   52 22.3 2.33   52 2.33 
NH4HCO3 85.6   79.1 1.08 85.6   1.08 
H2O Distilled   4000 18.0 222.04   4000 222.04 
Table 11: Synthetic urine composition 
Membrane NF 270 Units Time [min] 
Solution Synthetic   0 5 10 15 20 
Pressure Average kPa 1000 1000 1000 1000 1000 
 
Variance kPa 50 50 50 50 50 
Retentate Flow Reading l/min 1.65 1.65 1.65 1.65 1.65 
 
Variance l/min 0.02 0.02 0.02 0.02 0.02 
Mass Total g   30.20 30.48 30.28 30.25 
 
Cell g   16.68 16.79 16.43 16.26 
 
Net g 0.00 13.52 13.69 13.84 13.99 
Permeate Flow 
 





.h   147 149 150 152 




Variable Dilution Units Time [min] 
   
0 15 30 45 
   
1 2 3 1 2 3 1 2 3 1 2 3 
Total N 1:100 mg/l 3.3 3.3 3.3 2.4 2.4 2.4 2.6 2.6 2.6 2.3 2.3 2.3 
 
1:1 mg/l 3300 3300 3300 2400 2400 2400 2600 2600 2600 2300 2300 2300 
  
Rej 
   
27.27% 21.21% 30.30% 
               



















   
46.78% 44.92% 42.07% 
               
Chloride 1:100 mg/l 25 25 25 22 22 22 20 20 20 19 19 19 
 
1:1 mg/l 2500 2500 2500 2200 2200 2200 2000 2000 2000 1900 1900 1900 
  
Rej 
   
12.00% 20.00% 24.00% 
               



















   
76.82% 75.05% 80.70% 
               



















   
40.67% 40.38% 37.30% 
               
Ammonium 1:100 mg/l 16.9 16.9 16.9 7.7 8 8 10 10 10 13.4 13.6 13.6 
 
1:1 mg/l 1690 1690 1690 770 800 800 1000 1000 1000 1340 1360 1360 
  
Rej 
   
53.25% 40.83% 19.92% 
               
Table 13: Chemical analysis for synthetic urine through NF 270 membrane
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Membrane NF 90 Units Time [min] 
Solution Synthetic 
 
0 15 30 45 
Pressure Average kPa 1600 1600 1600 1600 
 
Variance kPa 50 50 50 50 
Retentate Flow Reading l/min 1.6 1.6 1.62 1.64 
 
Variance l/min 0.02 0.02 0.02 0.02 
Mass Total g 28.84 15.52 15.75 15.65 
 
Cell g 13.94 13.85 14.09 14.02 
 












6.06 6.01 5.89 
Table 14: Experimental data of synthetic urine run through NF 90 membrane 
Membrane NF 90 Units Time [min] 
Solution Synthetic 
 
0 5 10 15 20 
Pressure Average kPa 1000 1000 1000 1000 1000 
 
Variance kPa 50 50 50 50 50 
Retentate Flow Reading l/min 1.5 1.52 1.58 1.6 1.62 
 
Variance l/min 0.02 0.02 0.02 0.02 0.02 
Mass Total g 
 




16.69 16.79 16.44 16.25 
 












59.92 58.58 59.06 58.14 
Table 15: Water flux through fouled NF 90 membrane 
86 
 
Variable Dilution Units Time 
      0 15 30 45 
      1 2 3 1 2 3 1 2 3 1 2 3 
Total N 1:100 mg/l 2.8 2.8 2.8 2.6 2.5 2.4 2 2 2 1.5 1.3 1.4 
   1:1 mg/l 2800 2800 2800 2600 2500 2400 2000 2000 2000 1500 1300 1400 
    Rej       10.71% 28.57% 50.00% 
               
Potassium 1:1 mg/l 1818.96     548.24     593.83     557.1     
   1:1 mg/l 1818.96     548.24     593.83     557.1     
    Rej       69.86% 67.35% 69.37% 
               
Chloride 1:100 mg/l 35 35 35 9 10 10 15 15 15 11 12 13 
   1:1 mg/l 3500 3500 3500 900 1000 1000 1500 1500 1500 1100 1200 1300 
    Rej       72.38% 57.14% 65.71% 
               
Phosphorous 1:1 mg/l 422.06     135.35     147.78     181     
   1:1 mg/l 422.06     135.35     147.78     181     
    Rej       67.93% 64.99% 57.12% 
               
Sodium 1:1 mg/l 2160.99     693.88     734.67     695.38     
   1:1 mg/l 2160.99     693.88     734.67     695.38     
    Rej       67.89% 66.00% 67.82% 
               
Ammonium 1:100 mg/l 14.3 14.3 14.3 8.1 8.1 8.1 10 10 10 14.2 14.4 14.5 
   1:1 mg/l 1430 1430 1430 810 810 810 1000 1000 1000 1420 1440 1450 
    Rej       43.36% 30.07% -0.47% 
               
Table 16: Chemical analysis for synthetic urine through NF 90 membrane 
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Membrane XLE Units Time [min] 
Solution Synthetic   0 30 60 75 
Pressure Average kPa 1600 1600 2000 2500 
 
Variance kPa 50 50 50 50 
Retentate Flow Reading l/min 1.6 1.6 1.58 1.55 
 
Variance l/min 0.02 0.02 0.02 0.02 
Mass Total g 30.88 16.07 18.76 19.62 
 
Cell g 13.81 13.93 14.09 13.98 
 
Net g 17.07 2.14 4.68 5.64 
Permeate Flow 
 





.h   3.87 8.47 20.41 
Table 17: Experimental data of synthetic urine run through XLE membrane 
Membrane XLE Units Time [min] 
Solution Synthetic   0 5 10 15 20 
Pressure Average kPa 1000 1000 1000 1000 1000 
 
Variance kPa 50 50 50 50 50 
Retentate Flow Reading l/min 1.64 1.6 1.62 1.62 1.62 
 
Variance l/min 0.02 0.02 0.02 0.02 0.02 
Mass Total g   21.12 21.13 20.76 20.59 
 
Cell g   16.69 16.79 16.43 16.25 
 
Net g 0.00 4.43 4.34 4.32 4.33 
Permeate Flow 
 





.h   48.17 47.16 46.98 47.10 
Table 18: Water flux through fouled XLE membrane
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Variable Dilution Units Time 
      0 30 60 75 
      1 2 3 1 2 3 1 2 3 1 2 3 
Total N 1:100 mg/l 3.1 3.1 3.1 1.1 1.1 1.1 1.6 1.6 1.6 2.2 2.3 2.3 
  1:1  mg/l 3100 3100 3100 1100 1100 1100 1600 1600 1600 2200 2300 2300 
    Rej       64.52% 48.39% 26.88% 
               
Potassium 1:1 mg/l 2025.01     580.94     399.89     248.59     
   1:1 mg/l 2025.01     580.94     399.89     248.59     
    Rej       71.31% 80.25% 87.72% 
               
Chloride 1:100 mg/l 19 19 20 16 16 16 11 15 15 22 23 23 
   1:1 mg/l 1900 1900 2000 1600 1600 1600 1100 1500 1500 2200 2300 2300 
    Rej       17.24% 29.31% -17.24% 
               
Phosphorous 1:1 mg/l 483.51     186.64     127.49     204.99     
   1:1 mg/l 483.51     186.64     127.49     204.99     
    Rej       61.40% 73.63% 57.60% 
               
Sodium 1:1 mg/l 2287.87     728.12     485.09     305.32     
   1:1 mg/l 2287.87     728.12     485.09     305.32     
    Rej       68.17% 78.80% 86.65% 
               
Ammonium 1:100 mg/l 18.8 18.9 18.8 13.7 13.6 13.7 7.9 8 7.9 5.7 5.7 5.7 
   1:1 mg/l 1880 1890 1880 1370 1360 1370 790 800 790 570 570 570 
    Rej       27.43% 57.88% 69.73% 
               
Table 19: Chemical analysis for synthetic urine through XLE membrane
89 
 
8.3.3 Stored Urine 
Membrane NF 270 Units Time [min] 
Solution Stored   0 15 30 45 
Pressure Average kPa 1600 1600 1600 1600 
 
Variance kPa 50 50 50 50 
Retentate Flow Reading l/min 1.6 1.6 1.62 1.6 
 
Variance l/min 0.02 0.02 0.02 0.02 
Mass Total g 29.00 40.26 41.43 41.75 
 
Cell g 14.02 14.02 13.83 14.00 
 
Net g 14.99 26.24 27.59 27.75 
Permeate Flow 
 





.h   95.03 99.93 100.50 
Table 20: Experimental data of stored urine run through NF 270 membrane 
Membrane NF 270 Units Time [min] 
State Dirty   0 5 10 15 20 
Pressure Average kPa 1000 1000 1000 1000 1000 
 
Variance kPa 50 50 50 50 50 
Retentate Flow Reading l/min 1.6 1.6 1.6 1.6 1.6 
 
Variance l/min 0.02 0.02 0.02 0.02 0.02 
Mass Total g   29.89 30.20 30.00 29.83 
 
Cell g   16.68 16.79 16.43 16.25 
 
Net g 0.00 13.20 13.41 13.57 13.59 
Permeate Flow 
 





.h   143.46 145.70 147.43 147.63 
Table 21: Water flux through fouled NF 270 membrane 
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Variable Dilution Units Time 
      0 15 30 45 
      1 2 3 1 2 3 1 2 3 1 2 3 
Total N 1:50 mg/l 62 62 62 33 33 33 21 21 21 35 35 35 
  1:1  mg/l 3100 3100 3100 1650 1650 1650 1050 1050 1050 1750 1750 1750 
    Rej       46.77% 66.13% 43.55% 
               
Potassium 1:1 mg/l 785.33     385.67     295.18     314.53     
   1:1 mg/l 785.33     385.67     295.18     314.53     
    Rej       50.89% 62.41% 59.95% 
               
Chloride 1:50 mg/l 20 20 20 17 18 18 10 12 12 16 15 15 
   1:1 mg/l 1000 1000 1000 850 900 900 500 600 600 800 750 750 
    Rej       11.67% 43.33% 23.33% 
               
Phosphorous 1:1 mg/l 1237.39     696.17     1232.78     800.49     
   1:1 mg/l 1237.39     696.17     1232.78     800.49     
    Rej       43.74% 0.37% 35.31% 
               
Sodium 1:1 mg/l 2009.09     1107.4     935.02     1020.96     
   1:1 mg/l 2009.09     1107.4     935.02     1020.96     
    Rej       44.88% 53.46% 49.18% 
               
Ammonium 1:50 mg/l 50 50 50 22 22 22 14 14 14 33 33 33 
   1:1 mg/l 2500 2500 2500 1100 1100 1100 700 700 700 1650 1650 1650 
    Rej       56.00% 72.00% 34.00% 
               
Table 22: Chemical analysis for stored urine through NF 270 membrane 
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Membrane NF 90 Units Time [min] 
Solution Stored   0 15 30 45 
Pressure Average kPa 1600 1600 1600 1600 
 
Variance kPa 50 50 50 50 
Retentate Flow Reading l/min 1.62 1.6 1.62 1.64 
 
Variance l/min 0.02 0.02 0.02 0.02 
Mass Total g 35.46 15.92 16.14 16.09 
 
Cell g 13.94 13.89 14.09 14.02 
 
Net g 21.52 2.04 2.05 2.07 
Permeate Flow 
 





.h   7.37 7.43 7.51 
Table 23: Experimental data of stored urine run through NF 90 membrane 
Membrane NF 90 Units Time [min] 
State Dirty   0 5 10 15 20 
Pressure Average kPa 1000 1000 1000 1000 1000 
 
Variance kPa 50 50 50 50 50 
Retentate Flow Reading l/min 1.6 1.6 1.6 1.6 1.6 
 
Variance l/min 0.02 0.02 0.02 0.02 0.02 
Mass Total g   22.29 22.32 21.87 21.72 
 
Cell g   16.69 16.79 16.44 16.25 
 
Net g 0.00 5.60 5.53 5.43 5.47 
Permeate Flow 
 





.h   60.88 60.05 59.01 59.42 




Variable Dilution Units Time 
      0 15 30 45 
      1 2 3 1 2 3 1 2 3 1 2 3 
Total N 1:50 mg/l 63 63 63 30 30 30 30 30 30 41 41 41 
   1:1 mg/l 3150 3150 3150 1500 1500 1500 1500 1500 1500 2050 2050 2050 
    Rej       52.38% 52.38% 34.92% 
               
Potassium 1:1 mg/l 834.14     235.07     195.85     84.18     
  1:1 mg/l 834.14     235.07     195.85     84.18     
    Rej       71.82% 76.52% 89.91% 
               
Chloride 1:50 mg/l 21 21 21 8 8 8 6 6 7 7 7 7 
   1:1 mg/l 1050 1050 1050 400 400 400 300 300 350 350 350 350 
    Rej       61.90% 69.84% 66.67% 
               
Phosphorous     1:1 mg/l 1841.62     1719.32     1414.42     1181.98     
  1:1 mg/l 1841.62     1719.32     1414.42     1181.98     
    Rej       6.64% 23.20% 35.82% 
               
Sodium 1:1 mg/l 2261.84     690.07     700     245.04     
  1:1  mg/l 2261.84     690.07     700     245.04     
    Rej       69.49% 69.05% 89.17% 
               
Ammonium 1:50 mg/l 60 60 60 14 14 14 12 12 12 17 17 17 
   1:1 mg/l 3000 3000 3000 700 700 700 600 600 600 850 850 850 
    Rej       76.67% 80.00% 71.67% 
               
Table 25: Chemical analysis for stored urine through NF 90 membrane 
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Membrane XLE Units Time [min] 
Solution Stored   0 20 40 60 
Pressure Average kPa 1600 1600 2000 2500 
 
Variance kPa 50 50 50 50 
Retentate Flow Reading l/min 1.6 1.6 1.6 1.6 
 
Variance l/min 0.02 0.02 0.02 0.02 
Mass Total g 34.33 17.67 22.73 29.88 
 
Cell g 13.81 13.93 14.11 13.99 
 
Net g 20.52 3.73 8.63 15.89 
Permeate Flow 
 





.h   10.140 23.434 43.159 
Table 26: Experimental data of stored urine run through XLE membrane 
Membrane XLE Units Time [min] 
State Dirty   0 5 10 15 20 
Pressure Average kPa 1000 1000 1000 1000 1000 
 
Variance kPa 50 50 50 50 50 
Retentate Flow Reading l/min 1.6 1.6 1.6 1.6 1.6 
 
Variance l/min 0.02 0.02 0.02 0.02 0.02 
Mass Total g   22.68 22.66 22.37 22.04 
 
Cell g   16.70 16.79 16.44 16.26 
 
Net g 0.00 5.98 5.87 5.93 5.78 
Permeate Flow 
 





.h   64.94 63.73 64.47 62.84 
Table 27: Water flux through fouled XLE membrane 
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Variable Dilution Units Time 
      0 20 40 60 
      1 2 3 1 2 3 1 2 3 1 2 3 
Total N 1:50 mg/l 64 64 70 28 28 29 38 39 40 23 18 17 
    mg/l 3200 3200 3500 1400 1400 1450 1900 1950 2000 1150 900 850 
    Rej       57.07% 40.91% 70.71% 
               
Potassium 1:1 mg/l 750.23     106.27     26.3     0.77     
    mg/l 750.23     106.27     26.3     0.77     
    Rej       85.84% 96.49% 99.90% 
               
Chloride 1:50 mg/l 25 25 26 22 22 22 17 17 17 18 18 18 
    mg/l 1250 1250 1300 1100 1100 1100 850 850 850 900 900 900 
    Rej       13.16% 32.89% 28.95% 
               
Phosphorous 1:1 mg/l 1771.01     898.62     1212.13     1107.91     
    mg/l 1771.01     898.62     1212.13     1107.91     
    Rej       49.26% 31.56% 37.44% 
               
Sodium 1:1 mg/l 2216.22     351.48     152.63     78.84     
    mg/l 2216.22     351.48     152.63     78.84     
    Rej       84.14% 93.11% 96.44% 
               
Ammonium 1:50 mg/l 50 50 50 13 13 13 9 9 9 13 13 13 
    mg/l 2500 2500 2500 650 650 650 450 450 450 650 650 650 
    Rej       74.00% 82.00% 74.00% 
               
Table 28: Chemical analysis for stored urine through XLE membrane 
